"疾患名","疾患略語","手法","調査種別","対象者種別","専門","実績数","対象条件","薬剤","リクルート実施","クライアント","登録日"
"COPD","COPD","IDI","定性","患者","","8","重症と診断されても、憎悪／再燃がなしという対象者のみ実績あり","","アスマーク","The Planning Shop","2024-08-22"
"２型糖尿病","T2DM","IDI","定性","医師","一般内科","8","2型糖尿病患者を月に25人以上診療","","日経BP","Global Eyes Research","2024-08-23"
"２型糖尿病","T2DM","IDI","定性","医師","循環器内科","3","2型糖尿病患者を月に25人以上診療","","日経BP","Global Eyes Research","2024-08-24"
"２型糖尿病","T2DM","IDI","定性","医師","糖尿病内科","4","2型糖尿病患者を月に50人以上診療","","日経BP","Global Eyes Research","2024-08-25"
"２型糖尿病","T2DM","IDI","定性","医師","内分泌内科","1","2型糖尿病患者を月に50人以上診療","","日経BP","Global Eyes Research","2024-08-26"
"アルツハイマー型認知症","Alzheimer's Disease, AD","IDI","定性","医師","脳神経内科","10","アルツハイマー型認知症患者を月に20人以上診療","レカネマブ,レケンビ","キャンドゥ","Blue Matter Consulting","2024-08-27"
"アルツハイマー型認知症","Alzheimer's Disease, AD","IDI","定性","医師","精神科","2","アルツハイマー型認知症患者を月に20人以上診療","レカネマブ,レケンビ","キャンドゥ","Blue Matter Consulting","2024-08-28"
"アルツハイマー型認知症","Alzheimer's Disease, AD","IDI","定性","介護者","","3","軽度認知障害または軽度アルツハイマー型認知症と診断された患者の家族であること。","レカネマブ,レケンビ","3H","Blue Matter Consulting","2024-08-29"
"アルツハイマー型認知症","Alzheimer's Disease, AD","IDI","定性","介護者","","1","軽度認知障害または軽度アルツハイマー型認知症と診断された患者の家族であること。","レカネマブ,レケンビ","アスマーク","Blue Matter Consulting","2024-08-30"
"鼻茸を伴う慢性副鼻腔炎","CRSwNP","IDI","定性","医師","耳鼻咽喉科","4","中等度から重症の鼻茸を伴う慢性副鼻腔炎患者を3ヶ月に10人以上診療","レブリキズマブ,イブグリース","キャンドゥ","The Link Group","2024-08-31"
"慢性閉塞性肺疾患","Chronic Obstructive Pulmonary Disease, COPD","IDI","定性","医師","呼吸器内科","12","直近３ヶ月間に3種類の治療法を10人以上に実施","トゾラキマブ","キャンドゥ","The Link Group","2024-09-01"
"２型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","医師","循環器内科","4","1ヶ月に診療する２型糖尿病と診断された成人患者が41人以上であること","オルフォルグリプロン","キャンドゥ","The Link Group","2024-09-02"
"２型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","医師","内分泌代謝科/糖尿病内科","4","1ヶ月に診療する２型糖尿病と診断された成人患者が76人以上であること","オルフォルグリプロン","キャンドゥ","The Link Group","2024-09-03"
"転移性乳がん","Metastatic breast cancer","会場調査・IDI","定性","医師","乳腺外科","7","過去3ヶ月に治療や診断したホルモン受容体陽性・HER 2 陰性（HR+ HER2-）のステージ4の乳がん患者が10人以上、またはCDK4/6阻害薬の薬物治療が10％以上","イムルネストラント","キャンドゥ（日経）","The Link Group","2024-09-04"
"転移性乳がん","Metastatic breast cancer","会場調査・IDI","定性","医師","腫瘍内科","3","過去3ヶ月に治療や診断したホルモン受容体陽性・HER 2 陰性（HR+ HER2-）のステージ4の乳がん患者が10人以上、またはCDK4/6阻害薬の薬物治療が10％以上","イムルネストラント","キャンドゥ（日経）","The Link Group","2024-09-05"
"クローン病","Crohn’s Disease, CD","IDI","定性","医師","消化器内科","10","1ヶ月に診療する中等症、重症のクローン病患者が10人以上","ミリキズマブ,オンボー","キャンドゥ","The Link Group","2024-09-06"
"アルツハイマー型認知症","Alzheimer's Disease, AD","IDI","定性","医師","精神科","6","軽度認知障害(MCI)と軽度アルツハイマー型認知症を20人以上診療","OGA阻害剤","キャンドゥ","The Link Group","2024-09-07"
"アルツハイマー型認知症","Alzheimer's Disease, AD","IDI","定性","医師","神経内科","6","軽度認知障害(MCI)と軽度アルツハイマー型認知症を20人以上診療","OGA阻害剤","キャンドゥ","The Link Group","2024-09-08"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","神経内科","7","院内でMRI検査可、軽度認知障害(MCI)と軽度アルツハイマー型認知症を20人以上診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-09-09"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","精神科","3","院内でMRI検査可、軽度認知障害(MCI)と軽度アルツハイマー型認知症を20人以上診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-09-10"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","内科","8","過去1年に認知症外来に3名以上紹介、軽度認知障害(MCI)と軽度アルツハイマー型認知症を10人以上診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-09-11"
"慢性閉塞性肺疾患","COPD","IDI","定性","医師","呼吸器内科","8","COPD患者を月に41名以上診察、直近３ヶ月間に3種類の治療法を10人以上に実施","トゾラキマブ","キャンドゥ","The Link Group","2024-09-12"
"プレクリニカルアルツハイマー病","Preclinical Alzheimer's Disease, PCAD","IDI","定性","患者","","16","55~79歳のアルツハイマー病及び、認知症（血管性、レビー小体型、ピック型、前頭側頭型を含む） と診断されたことのないプレクリニカル患者及びMCI患者 ","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-09-13"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","神経内科","8","院内でMRI検査可、レカネマブの初回投与が可能な施設、軽度認知障害(MCI)と軽度アルツハイマー型認知症を20人以上診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-09-14"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","精神科","2","院内でMRI検査可、レカネマブの初回投与が可能な施設、軽度認知障害(MCI)と軽度アルツハイマー型認知症を20人以上診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-09-15"
"プレクリニカルアルツハイマー病／軽度認知障害","Preclinical Alzheimer's Disease, PCAD, MCI","会場調査・IDI","定性","医師","神経内科","6","院内でMRI検査可、軽度認知障害(MCI)と軽度アルツハイマー型認知症を20人以上診療","ドナネマブ,ケサンラ","キャンドゥ（日経）","The Link Group","2024-09-16"
"プレクリニカルアルツハイマー病／軽度認知障害","Preclinical Alzheimer's Disease, PCAD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","内科","5","軽度認知障害(MCI)と軽度アルツハイマー型認知症を10人以上診療","ドナネマブ,ケサンラ","キャンドゥ（日経）","The Link Group","2024-09-17"
"プレクリニカルアルツハイマー病","Preclinical Alzheimer's Disease, PCAD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","患者","","10","脳神経系の疾患の診断を受けておらず、薬や自分の将来について積極的であること","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-09-18"
"プレクリニカルアルツハイマー病","Preclinical Alzheimer's Disease, PCAD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","介護者","","3","脳神経系の疾患の診断を受けておらず、薬や自分の将来について積極的な患者さんを介護しているご家族","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-09-19"
"転移性乳がん","Metastatic breast cancer","会場調査・IDI","定性","医師","乳腺外科","9","過去3ヶ月に治療や診断したホルモン受容体陽性・HER 2 陰性（HR+ HER2-）のステージ4の乳がん患者が10人以上、またはCDK4/6阻害薬の薬物治療が10％以上。","イムルネストラント","キャンドゥ（日経）","The Link Group","2024-09-20"
"転移性乳がん","Metastatic breast cancer","会場調査・IDI","定性","医師","腫瘍内科","3","過去3ヶ月に治療や診断したホルモン受容体陽性・HER 2 陰性（HR+ HER2-）のステージ4の乳がん患者が10人以上、またはCDK4/6阻害薬の薬物治療が10％以上。","イムルネストラント","キャンドゥ（日経）","The Link Group","2024-09-21"
"鼻茸を伴う慢性副鼻腔炎","Chronic Rhinosinusitis with Nasal Polyps, CRSwNP","IDI","定性","患者","","3","鼻茸を伴う慢性副鼻腔炎と診断され、生物学的製剤などの薬剤を使用したことがある","レブリキズマブ,イブグリース","アスマーク","The Link Group","2024-09-22"
"プレクリニカルアルツハイマー病／軽度認知障害","Preclinical Alzheimer's Disease, PCAD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","内科","12","MCI,軽度アルツハイマー型認知症患者を10人以上診療し、そのうちの30％以上がMCIやアルツハイマーの治療のために処方薬を飲んでいる","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-09-23"
"プレクリニカルアルツハイマー病／軽度認知障害","Preclinical Alzheimer's Disease, PCAD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","神経内科","6","MCI,軽度アルツハイマー型認知症患者を20人以上を診療し、そのうちの30％以上がMCIやアルツハイマーの治療のために処方薬を飲んでいる","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-09-24"
"注意欠如・多動性障害","Attention Deficit Hyperactivity Disorder, ADHD","IDI","定性","医師","精神科","5","1ヶ月に診療するADHD患者が25人以上","センタナファジン","キャンドゥ","The Link Group","2024-09-25"
"注意欠如・多動性障害","Attention Deficit Hyperactivity Disorder, ADHD","IDI","定性","医師","小児精神科","5","1ヶ月に診療するADHD患者が25人以上","センタナファジン","キャンドゥ","The Link Group","2024-09-26"
"注意欠如・多動性障害","Attention Deficit Hyperactivity Disorder, ADHD","IDI","定性","医師","小児科","5","1ヶ月に診療するADHD患者が41人以上","センタナファジン","キャンドゥ","The Link Group","2024-09-27"
"アトピー性皮膚炎","Atopic Dermatitis, AD","会場調査・IDI","定性","医師","皮膚科","10","1ヶ月にアトピー性皮膚炎の成人患者を10人以上診療","レブリキズマブ,イブグリース","キャンドゥ","The Link Group","2024-09-28"
"IgA腎症","IgA nephropathy, IgAN","IDI","定性","医師","腎臓内科","5","平均的な12ヶ月間に、免疫グロブリンA腎症(IgA腎症/ベルジェ病)と診断された患者を10人以上診療","シベプレンリマブ","キャンドゥ","The Link Group","2024-09-29"
"IgA腎症","IgA nephropathy, IgAN","IDI","定性","患者","","3","IgA腎症の診断確定に腎生検を受けた、腎臓内科／腎臓専門医を受診している","シベプレンリマブ","アスマーク","The Link Group","2024-09-30"
"IgA腎症","IgA nephropathy, IgAN","IDI","定性","患者","","1","IgA腎症の診断確定に腎生検を受けた、腎臓内科／腎臓専門医を受診している","シベプレンリマブ","3H","The Link Group","2024-10-01"
"プレクリニカルアルツハイマー病","Preclinical Alzheimer's Disease, PCAD/Mild Cognitive Impairment, MCI","IDI","定性","医師","内科","4","MCIと軽度アルツハイマー型認知症を10名以上診療している","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-10-02"
"プレクリニカルアルツハイマー病","Preclinical Alzheimer's Disease, PCAD/Mild Cognitive Impairment, MCI","IDI","定性","医師","神経内科","3","MCIと軽度アルツハイマー型認知症を20名以上診療している","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-10-03"
"プレクリニカルアルツハイマー病","Preclinical Alzheimer's Disease, PCAD/Mild Cognitive Impairment, MCI","IDI","定性","医師","精神科","3","MCIと軽度アルツハイマー型認知症を20名以上診療している","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-10-04"
"鼻茸を伴う慢性副鼻腔炎","Chronic Rhinosinusitis with Nasal Polyps, CRSwNP","IDI","定性","患者","","3","鼻茸を伴う慢性副鼻腔炎と診断され、現在、アレルギー科、耳鼻咽喉科、アレルギー呼吸科のいずれかで診療を受けている。","レブリキズマブ,イブグリース","アスマーク","The Link Group","2024-10-05"
"プレクリニカルアルツハイマー病","Preclinical Alzheimer's Disease, PCAD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","患者","","12","脳神経系の疾患の診断を受けておらず脳の健康状態に前向きであり、過去一年で目立った記憶力の低下がない","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-10-06"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","内科","6","施設にMRIがなく、抗アミロイドβ抗体の初回投与は不可、6ヶ月以降であれば投与可、MCIと軽度ADを10人以上診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-10-07"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","精神科","3","施設にMRIがなく、抗アミロイドβ抗体の初回投与は不可、6ヶ月以降であれば投与可、MCIと軽度ADを10人以上診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-10-08"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","神経内科","3","施設にMRIがなく、抗アミロイドβ抗体の初回投与は不可、6ヶ月以降であれば投与可、MCIと軽度ADを10人以上診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-10-09"
"慢性神経障害性疼痛","Chronic neuropathic pain","IDI","定性","医師","神経内科","2","過去3ヶ月に多発神経障害又は末梢神経障害痛の患者さんを20名以上診察","SSTR4アゴニスト","キャンドゥ","The Link Group","2024-10-10"
"慢性神経障害性疼痛","Chronic neuropathic pain","IDI","定性","医師","痛み専門医","2","過去3ヶ月に多発神経障害又は末梢神経障害痛の患者さんを20名以上診察","SSTR4アゴニスト","キャンドゥ","The Link Group","2024-10-11"
"慢性神経障害性疼痛","Chronic neuropathic pain","IDI","定性","医師","整形外科","4","過去3ヶ月に多発神経障害又は末梢神経障害痛の患者さんを20名以上診察","SSTR4アゴニスト","キャンドゥ","The Link Group","2024-10-12"
"慢性神経障害性疼痛","Chronic neuropathic pain","IDI","定性","医師","内分泌代謝科/糖尿病内科","2","過去3ヶ月に多発神経障害又は末梢神経障害痛の患者さんを10名以上診察","SSTR4アゴニスト","キャンドゥ","The Link Group","2024-10-13"
"慢性神経障害性疼痛","Chronic neuropathic pain","IDI","定性","医師","内科","2","過去3ヶ月に多発神経障害又は末梢神経障害痛の患者さんを10名以上診察","SSTR4アゴニスト","キャンドゥ","The Link Group","2024-10-14"
"クローン病・潰瘍性大腸炎","Crohn's Disease, CD/Ulcerative Colitis, UC","IDI","定性","医師","消化器内科","10","1ヶ月に中等度～重度のクローン病と潰瘍性大腸炎の患者を10人以上診療","ミリキズマブ,オンボー","キャンドゥ","The Link Group","2024-10-15"
"急性骨髄性白血病","Acute Myeloid Leukemia, AML","IDI","定性","医師","血液内科","10","過去6ヶ月に急性骨髄性白血病患者（急性前骨髄球性白血病(APL、M3サブタイプ)は除く）を1人以上診療","ベネクレクスタ,ベネトクラクス","キャンドゥ","The Link Group","2024-10-16"
"転移性乳がん","Metastatic breast cancer","IDI","定性","医師","腫瘍内科","2","過去3ヶ月に治療や診断したホルモン受容体陽性・HER 2 陰性（HR+ HER2-）のステージ4の乳がん患者が10人以上、またはCDK4/6阻害薬の薬物治療が10％以上","イムルネストラント","キャンドゥ","The Link Group","2024-10-17"
"転移性乳がん","Metastatic breast cancer","IDI","定性","医師","乳腺外科","4","過去3ヶ月に治療や診断したホルモン受容体陽性・HER 2 陰性（HR+ HER2-）のステージ4の乳がん患者が10人以上、またはCDK4/6阻害薬の薬物治療が10％以上。","イムルネストラント","キャンドゥ","The Link Group","2024-10-18"
"IgA腎症","IgA nephropathy, IgAN","IDI","定性","医師","腎臓内科","6","12ヶ月間に免疫グロブリンA腎症と診断された患者を2人以上診療","シベプレンリマブ","キャンドゥ","The Link Group","2024-10-19"
"アルコール・タバコ使用障害","Alcohol and Tobacco Use Disorders","会場調査・IDI","定性","医師","内科","5","１ヶ月に軽度及び中等度～重度アルコール使用障害患者を26人以上診療している精神科医、消化器専門医、または軽度アルコール使用患者を11人以上診療しているかかりつけ医","チルゼパチド,マンジャロ","キャンドゥ","The Link Group","2024-10-20"
"アルコール・タバコ使用障害","Alcohol and Tobacco Use Disorders","会場調査・IDI","定性","医師","精神科","4","１ヶ月に軽度及び中等度～重度アルコール使用障害患者を26人以上診療している精神科医、消化器専門医、または軽度アルコール使用患者を11人以上診療しているかかりつけ医","チルゼパチド,マンジャロ","キャンドゥ","The Link Group","2024-10-21"
"アルコール・タバコ使用障害","Alcohol and Tobacco Use Disorders","会場調査・IDI","定性","医師","消化器内科","4","１ヶ月に軽度及び中等度～重度アルコール使用障害患者を26人以上診療している精神科医、消化器専門医、または軽度アルコール使用患者を11人以上診療しているかかりつけ医","チルゼパチド,マンジャロ","キャンドゥ","The Link Group","2024-10-22"
"アルコール・タバコ使用障害","Alcohol and Tobacco Use Disorders","会場調査・IDI","定性","医師","禁煙外来","4","１ヶ月に軽度及び中等度～重度アルコール使用障害患者を26人以上診療している精神科医、消化器専門医、または軽度アルコール使用患者を11人以上診療しているかかりつけ医","チルゼパチド,マンジャロ","キャンドゥ","The Link Group","2024-10-23"
"アルコール・タバコ使用障害","Alcohol and Tobacco Use Disorders","会場調査・IDI","定性","医師","呼吸器内科","4","１ヶ月に軽度及び中等度～重度アルコール使用障害患者を26人以上診療している精神科医、消化器専門医、または軽度アルコール使用患者を11人以上診療しているかかりつけ医","チルゼパチド,マンジャロ","キャンドゥ","The Link Group","2024-10-24"
"アルコール・タバコ使用障害","Alcohol and Tobacco Use Disorders","会場調査・IDI","定性","患者","","8","週に1～2回以上アルコールを飲む","チルゼパチド,マンジャロ","アスマーク","The Link Group","2024-10-25"
"アルコール・タバコ使用障害","Alcohol and Tobacco Use Disorders","会場調査・IDI","定性","患者","","8","1日に何度も紙巻タバコを吸う","チルゼパチド,マンジャロ","アスマーク","The Link Group","2024-10-26"
"筋層浸潤性膀胱がん","Muscle Invasive Bladder Cancer, MIBC","IDI","定性","医師","泌尿器科","6","過去3ヶ月間に尿路上皮がん患者を10人以上診療、筋層浸潤性膀胱がん /ステージII-IVA患者を５名以上診療","","キャンドゥ","The Link Group","2024-10-27"
"クローン病","Crohn's disease, CD","IDI","定性","患者","","7","中等度から重度のクローン病で3～25年前に診断され、治療薬を現在服用／使用している、または過去に服用／使用していた																																														","ミリキズマブ,オンボー","アスマーク","The Link Group","2024-10-28"
"クローン病","Crohn's disease, CD","IDI","定性","患者","","1","中等度から重度のクローン病で3～25年前に診断され、治療薬を現在服用／使用している、または過去に服用／使用していた																																														","ミリキズマブ,オンボー","3H","The Link Group","2024-10-29"
"転移性乳がん","Metastatic breast cancer","IDI","定性","医師","腫瘍内科","3","過去3ヶ月に治療や診断したホルモン受容体陽性・HER 2 陰性（HR+ HER2-）のステージ4の乳がん患者が10人以上、またはCDK4/6阻害薬の薬物治療が10％以上。","イムルネストラント","キャンドゥ","The Link Group","2024-10-30"
"転移性乳がん","Metastatic breast cancer","IDI","定性","医師","乳腺外科","9","過去3ヶ月に治療や診断したホルモン受容体陽性・HER 2 陰性（HR+ HER2-）のステージ4の乳がん患者が10人以上、またはCDK4/6阻害薬の薬物治療が10％以上。","イムルネストラント","キャンドゥ","The Link Group","2024-10-31"
"筋層非浸潤性膀胱がん・筋層浸潤性膀胱がん","Non-Muscle Invasive Bladder Cancer, NMIBC, Muscle Invasive Bladder Cancer, MIBC","IDI","定性","医師","泌尿器科","10","過去３ヶ月に膀胱がん患者を10人以上診療、筋層非浸潤性膀胱がんステージ0-I 5人以上、筋層浸潤性膀胱がんステージII-IVA","","キャンドゥ","The Link Group","2024-11-01"
"統合失調症","Schizophrenia","IDI","定性","患者","","4","１年以上前に診断を受け、1年以内に医師の診察を受けている18～64歳の統合失調症患者","ウロタロント","アスマーク","The Link Group","2024-11-02"
"統合失調症","Schizophrenia","IDI","定性","介護者","","4","１年以上前に診断を受け、1年以内に医師の診察を受けている18～64歳の統合失調症患者さんをサポートしているご家族","ウロタロント","アスマーク","The Link Group","2024-11-03"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","内科","6","軽度認知障害(MCI)と軽度アルツハイマー型認知症を10人以上診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-11-04"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","神経内科","3","軽度認知障害(MCI)と軽度アルツハイマー型認知症を20人以上診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-11-05"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","精神科","3","軽度認知障害(MCI)と軽度アルツハイマー型認知症を20人以上診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-11-06"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","医師","泌尿器科","12","過去1ヶ月に前立腺がん患者を３人以上診察し、転移性去勢抵抗性前立腺がん、転移性去勢感受性前立腺がんをそれぞれ3人以上いる","アベマシクリブ,ベージニオ","キャンドゥ","The Link Group","2024-11-07"
"統合失調症","Schizophrenia","IDI","定性","医師","精神科","4","治療や管理している統合失調症患者を40人以上診療","ウロタロント","キャンドゥ","The Link Group","2024-11-08"
"統合失調症","Schizophrenia","IDI","定性","医師","精神科","4","治療や管理している統合失調症患者を40人以上診療","ウロタロント","キャンドゥ","The Link Group","2024-11-09"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","患者","","6","記憶力や思考力が以前とは違うと感じADと診断されている場合は、早期、軽度まで","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-11-10"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","患者","","4","記憶力や思考力が以前とは違うと感じADと診断されている場合は、早期、軽度まで","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-11-11"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","介護者","","4","記憶力や思考力が以前とは違うと感じADと診断されている場合は、軽度までの患者さんご家族","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-11-12"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Group","定性","患者","","16","記憶力や思考力が以前とは違うと感じADと診断されている場合は、早期、軽度まで","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-11-13"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","患者","","4","記憶力や思考力が以前とは違うと感じADと診断されている場合は、早期、軽度まで","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-11-14"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","介護者","","4","記憶力や思考力が以前とは違うと感じADと診断されている場合は、軽度までの患者さんご家族","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-11-15"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","患者","","10","記憶力や思考力が以前とは違うと感じADと診断されている場合は、早期、軽度まで","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-11-16"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","患者","","6","記憶力や思考力が以前とは違うと感じADと診断されている場合は、早期、軽度まで","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-11-17"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","介護者","","6","記憶力や思考力が以前とは違うと感じADと診断されている場合は、軽度までの患者さんご家族","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-11-18"
"新型コロナウィルス感染症","COVID","IDI","定性","医師","血液内科","1","過去3ヶ月に診療した免疫不全患者が120人以上","","キャンドゥ","The Link Group","2024-11-19"
"新型コロナウィルス感染症","COVID","IDI","定性","医師","血液腫瘍内科","1","過去3ヶ月に診療した免疫不全患者が120人以上","","キャンドゥ","The Link Group","2024-11-20"
"新型コロナウィルス感染症","COVID","IDI","定性","医師","腎臓内科","1","過去3ヶ月に診療した免疫不全患者が120人以上","","キャンドゥ","The Link Group","2024-11-21"
"新型コロナウィルス感染症","COVID","IDI","定性","医師","感染症専門医","1","過去3ヶ月に診療した免疫不全患者が120人以上","","キャンドゥ","The Link Group","2024-11-22"
"新型コロナウィルス感染症","COVID","IDI","定性","医師","総合診療科","1","過去3ヶ月に診療した免疫不全患者が60人以上","","キャンドゥ","The Link Group","2024-11-23"
"新型コロナウィルス感染症","COVID","IDI","定性","医師","リウマチ科","1","過去3ヶ月に診療した免疫不全患者が120人以上","","キャンドゥ","The Link Group","2024-11-24"
"2型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","患者","","12","25～60歳、6ヶ月以上15年以内に2型糖尿病と診断され、医師からHbA1cをコントロールできていないと言われ、内服薬、インスリン以外の注射、または基礎インスリンを使用している","GLP-1","アスマーク","The Link Group","2024-11-25"
"筋萎縮性側索硬化症","Amyotrophic Lateral Sclerosis, ALS","IDI","定性","医師","神経内科","5","過去12ヶ月に診療したALS患者が５人以上","レリブリオ","PDリサーチ","The Link Group","2024-11-26"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","神経内科","8","MCIと軽度アルツハイマー型認知症患者を20人以上診療","ドナネマブ,ケサンラ","PDリサーチ","The Link Group","2024-11-27"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","老年科","4","MCIと軽度アルツハイマー型認知症患者を10人以上診療","ドナネマブ,ケサンラ","PDリサーチ","The Link Group","2024-11-28"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","精神科","4","MCIと軽度アルツハイマー型認知症患者を20人以上診療","ドナネマブ,ケサンラ","PDリサーチ","The Link Group","2024-11-29"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","医師","泌尿器科","12","過去1ヶ月に前立腺がん患者を3人以上、転移性去勢感受性前立腺がん患者を3人以上診療","アベマシクリブ,ベージニオ","PDリサーチ","The Link Group","2024-11-30"
"糖尿病性末梢神経障害性疼痛","Diabetic Peripheral Neuropathic Pain, DPNP","会場調査・IDI","定性","医師","内科","3","2型糖尿病患者を20名以上、中等度から重度の糖尿病性抹消神経障害性疼痛を2名以上診療","SSTR4アゴニスト","キャンドゥ","The Link Group","2024-12-01"
"糖尿病性末梢神経障害性疼痛","Diabetic Peripheral Neuropathic Pain, DPNP","会場調査・IDI","定性","医師","痛み専門医","2","2型糖尿病患者を20名以上、中等度から重度の糖尿病性抹消神経障害性疼痛を5名以上診療","SSTR4アゴニスト","キャンドゥ","The Link Group","2024-12-02"
"糖尿病性末梢神経障害性疼痛","Diabetic Peripheral Neuropathic Pain, DPNP","会場調査・IDI","定性","医師","神経内科","2","2型糖尿病患者を20名以上、中等度から重度の糖尿病性抹消神経障害性疼痛を5名以上診療","SSTR4アゴニスト","キャンドゥ","The Link Group","2024-12-03"
"糖尿病性末梢神経障害性疼痛","Diabetic Peripheral Neuropathic Pain, DPNP","会場調査・IDI","定性","医師","内分泌科","3","2型糖尿病患者を40名以上、中等度から重度の糖尿病性抹消神経障害性疼痛を5名以上診療","SSTR4アゴニスト","キャンドゥ","The Link Group","2024-12-04"
"クローン病","Crohn’s Disease, CD","IDI","定性","医師","消化器内科","7","1ヶ月に診療している中等度と重度クローン病患者が10人以上","ミリキズマブ,オンボー","PDリサーチ","The Link Group","2024-12-05"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","精神科","4","過去3ヶ月に診察した患者が75人以上で、アルツハイマー型認知症とMCI患者の合計が30人以上","TAUVID","キャンドゥ","The Link Group","2024-12-06"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","神経内科","4","過去3ヶ月に診察した患者が75人以上で、アルツハイマー型認知症とMCI患者の合計が30人以上","TAUVID","キャンドゥ","The Link Group","2024-12-07"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","医師","核医学専門医","4","過去3ヶ月に、神経内科・脳神経外科・精神科からのPET検査の依頼が、全体の15％以上を占めている","TAUVID","キャンドゥ","The Link Group","2024-12-08"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","患者","","8","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度まで","TAUVID","アスマーク","The Link Group","2024-12-09"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","患者","","6","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度まで","TAUVID","アスマーク","The Link Group","2024-12-10"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","介護者","","6","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度まで","TAUVID","アスマーク","The Link Group","2024-12-11"
"クローン病","Crohn’s Disease, CD","IDI","定性","医師","消化器内科","12","1ヶ月に診療している中等度と重度クローン病患者が10人以上","ミリキズマブ,オンボー","キャンドゥ","The Link Group","2024-12-12"
"ウイルス性下気道疾患","Lower Respiratory Tract Disease, LRTD","IDI","定性","医師","内科","4","1ヶ月にウイルス性肺感染症等による急性呼吸不全成人入院患者を30名以上治療管理し、そのうち10％以上がウイルス性肺炎","トソラキマブ","キャンドゥ","The Link Group","2024-12-13"
"ウイルス性下気道疾患","Lower Respiratory Tract Disease, LRTD","IDI","定性","医師","感染症科","2","1ヶ月にウイルス性肺感染症等による急性呼吸不全成人入院患者を30名以上治療管理し、そのうち10％以上がウイルス性肺炎","トソラキマブ","キャンドゥ","The Link Group","2024-12-14"
"ウイルス性下気道疾患","Lower Respiratory Tract Disease, LRTD","IDI","定性","医師","集中治療","2","1ヶ月にウイルス性肺感染症等による急性呼吸不全成人入院患者を30名以上治療管理し、そのうち10％以上がウイルス性肺炎","トソラキマブ","キャンドゥ","The Link Group","2024-12-15"
"ウイルス性下気道疾患","Lower Respiratory Tract Disease, LRTD","IDI","定性","医師","呼吸器内科","2","1ヶ月にウイルス性肺感染症等による急性呼吸不全成人入院患者を30名以上治療管理し、そのうち10％以上がウイルス性肺炎","トソラキマブ","キャンドゥ","The Link Group","2024-12-16"
"ウイルス性下気道疾患","Lower Respiratory Tract Disease, LRTD","IDI","定性","医師","救急医療","2","1ヶ月にウイルス性肺感染症等による急性呼吸不全成人入院患者を30名以上治療管理し、そのうち10％以上がウイルス性肺炎(救急医のみ外来患者も含めてカウント)","トソラキマブ","キャンドゥ","The Link Group","2024-12-17"
"アルツハイマー病","Alzheimer's Disease, AD","IDI","定性","KOL","神経内科","1","過去2年間に臨床試験の治験責任医師／治験分担医師、バイオテクノロジー企業や製薬会社で報酬を伴うコンサルタント、医学論文の主著者／共著者、または国内外の医学会議で講演者または発表者を務めた","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-12-18"
"アルツハイマー病","Alzheimer's Disease, AD","IDI","定性","KOL","循環器科","1","過去2年間に臨床試験の治験責任医師／治験分担医師、バイオテクノロジー企業や製薬会社で報酬を伴うコンサルタント、医学論文の主著者／共著者、または国内外の医学会議で講演者または発表者を務めた","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2024-12-19"
"アルツハイマー病","Alzheimer's Disease, AD","IDI","定性","介護者","","4","アルツハイマー以外の神経疾患のご家族をサポートしている","ドナネマブ,ケサンラ","アスマーク","The Link Group","2024-12-20"
"アトピー性皮膚炎","Atopic Dermatitis, AD","IDI","定性","医師","皮膚科","9","1ヶ月に50人以上の患者を診療し、アトピー性皮膚炎／湿疹の成人患者が5人以上","レブリキズマブ,イブグリース","キャンドゥ","The Link Group","2024-12-21"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","医師","腫瘍内科","2","過去3ヶ月に転移性前立腺がん患者を10人以上診療","アベマシクリブ,ベージニオ","キャンドゥ","The Link Group","2024-12-22"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","医師","泌尿器科","6","過去3ヶ月に転移性前立腺がん患者を10人以上診療","アベマシクリブ,ベージニオ","キャンドゥ","The Link Group","2024-12-23"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","患者","","5","転移性ホルモン感受性前立腺がんと診断され、現在治療を受けている、または過去に治療を受けていた","アベマシクリブ,ベージニオ","アスマーク","The Link Group","2024-12-24"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","患者","","3","転移性去勢抵抗性前立腺がんと診断され、現在治療を受けている、または過去に治療を受けていた","アベマシクリブ,ベージニオ","アスマーク","The Link Group","2024-12-25"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","患者","","1","転移性去勢抵抗性前立腺がんと診断され、現在治療を受けている、または過去に治療を受けていた","アベマシクリブ,ベージニオ","3Hメディソリューションズ","The Link Group","2024-12-26"
"拡張不全","Heart Failure with preserved Ejection Fraction, HFpEF","IDI","定性","医師","循環器科","10","1ヶ月に慢性心不全患者を30人以上、拡張不全と収縮不全をそれぞれ30人以上診療している","ミエロペルオキシダーゼ阻害薬","キャンドゥ","The Link Group","2024-12-27"
"乳がん","Breast cancer","IDI","定性","医師","乳腺外科","8","過去3ヶ月間に診療したホルモン受容体陽性HER2陰性乳癌患者のうちステージⅠ、Ⅱ、Ⅲ （転移なし） が９人以上、ステージⅣ（転移あり） が15人以上","アベマシクリブ,ベージニオ","PDリサーチ","The Link Group","2024-12-28"
"乳がん","Breast cancer","IDI","定性","医師","一般外科","3","過去3ヵ月間に診療したホルモン受容体陽性HER2陰性乳癌患者のうちステージⅠ、Ⅱ、Ⅲ （転移なし） が９人以上、ステージⅣ（転移あり） が15人以上","アベマシクリブ,ベージニオ","PDリサーチ","The Link Group","2024-12-29"
"乳がん","Breast cancer","IDI","定性","医師","乳腺外科","2","過去3ヶ月間に診療したホルモン受容体陽性HER2陰性乳癌患者のうちステージⅠ、Ⅱ、Ⅲ （転移なし） が９人以上、ステージⅣ（転移あり） が15人以上","アベマシクリブ,ベージニオ","キャンドゥ","The Link Group","2024-12-30"
"乳がん","Breast cancer","IDI","定性","医師","一般外科","1","過去3ヵ月間に診療したホルモン受容体陽性HER2陰性乳癌患者のうちステージⅠ、Ⅱ、Ⅲ （転移なし） が９人以上、ステージⅣ（転移あり） が15人以上","アベマシクリブ,ベージニオ","キャンドゥ","The Link Group","2024-12-31"
"動脈硬化性心疾患","Atherosclerotic Cardiovascular Disease, ASCVD","IDI","定性","医師","循環器科","5","1ヶ月に動脈硬化症／動脈硬化性心血管疾患患者を30人以上診療","Lp(a)阻害剤","キャンドゥ","The Link Group","2025-01-01"
"動脈硬化性心疾患","Atherosclerotic Cardiovascular Disease, ASCVD","IDI","定性","医師","内科","4","1ヶ月に動脈硬化症／動脈硬化性心血管疾患患者を20人以上診療","Lp(a)阻害剤","キャンドゥ","The Link Group","2025-01-02"
"動脈硬化性心疾患","Atherosclerotic Cardiovascular Disease, ASCVD","IDI","定性","医師","内分泌科／代謝内科／糖尿病内科","1","1ヶ月に動脈硬化症／動脈硬化性心血管疾患患者を30人以上診療","Lp(a)阻害剤","キャンドゥ","The Link Group","2025-01-03"
"動脈硬化性心疾患","Atherosclerotic Cardiovascular Disease, ASCVD","IDI","定性","患者","","5","1次予防患者：動脈硬化性脳血管障害、冠動脈疾患、末梢動脈疾患、2型糖尿病のいずれかと診断されている、心血管の健康管理のために薬剤を服用している、または服用していた","Lp(a)阻害剤","アスマーク","The Link Group","2025-01-04"
"動脈硬化性心疾患","Atherosclerotic Cardiovascular Disease, ASCVD","IDI","定性","患者","","4","2次予防患者：CVイベントの既往歴あり、心血管の健康管理のために薬剤を服用している、または服用していた","Lp(a)阻害剤","アスマーク","The Link Group","2025-01-05"
"2型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","医師","糖尿病内科","2","1ヶ月に2型糖尿病患者を80人以上診療、自身でインスリン以外の注射製剤および基礎インスリン製剤の治療を開始","GLP-1","キャンドゥ","The Link Group","2025-01-06"
"2型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","医師","内科","3","1ヶ月に2型糖尿病患者を40名以上診療、自身でインスリン以外の注射製剤および基礎インスリン製剤の治療を開始","GLP-1","キャンドゥ","The Link Group","2025-01-07"
"2型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","医師","循環器内科","2","1ヶ月に2型糖尿病患者を40名以上診療、自身でインスリン以外の注射製剤および基礎インスリン製剤の治療を開始","GLP-1","キャンドゥ","The Link Group","2025-01-08"
"2型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","医師","消化器内科","1","1ヶ月に2型糖尿病患者を40名以上診療、自身でインスリン以外の注射製剤および基礎インスリン製剤の治療を開始","GLP-1","キャンドゥ","The Link Group","2025-01-09"
"転移性乳がん","Metastatic breast cancer","IDI","定性","医師","乳腺外科","7","過去3ヶ月にホルモン受容体陽性HER2陰性 (HR陽性HER2陰性) のステージ4の乳癌患者を10人以上診療","イムルネストラント","キャンドゥ","The Link Group","2025-01-10"
"転移性乳がん","Metastatic breast cancer","IDI","定性","医師","腫瘍内科","3","過去3ヶ月にホルモン受容体陽性HER2陰性 (HR陽性HER2陰性) のステージ4の乳癌患者を10人以上診療","イムルネストラント","キャンドゥ","The Link Group","2025-01-11"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","精神科","3","過去3ヶ月に診察した患者が75人以上で、アルツハイマー型認知症とMCI患者の合計が30人以上","TAUVID","キャンドゥ","The Link Group","2025-01-12"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","内科","2","過去3ヶ月に診察した患者が75人以上で、アルツハイマー型認知症とMCI患者の合計が30人以上","TAUVID","キャンドゥ","The Link Group","2025-01-13"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","脳神経外科","3","過去3ヶ月に診察した患者が75人以上で、アルツハイマー型認知症とMCI患者の合計が30人以上","TAUVID","キャンドゥ","The Link Group","2025-01-14"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","老年科","1","過去3ヶ月に診察した患者が75人以上で、アルツハイマー型認知症とMCI患者の合計が30人以上","TAUVID","キャンドゥ","The Link Group","2025-01-15"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","神経内科","3","過去3ヶ月に診察した患者が75人以上で、アルツハイマー型認知症とMCI患者の合計が30人以上","TAUVID","キャンドゥ","The Link Group","2025-01-16"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","核医学専門医","3","勤務先施設にPET装置があり、過去3ヶ月に、神経内科・脳神経外科・精神科からのPET検査の依頼が、全体の15％以上を占める","TAUVID","キャンドゥ","The Link Group","2025-01-17"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","患者","","8","記憶力や思考力が以前とは違うと感じ、アルツハイマーと診断されている場合は、早期、軽度まで","TAUVID","アスマーク","The Link Group","2025-01-18"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","Dyad","定性","患者","","6","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度までの患者さんとご家族","TAUVID","アスマーク","The Link Group","2025-01-19"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","Dyad","定性","介護者","","6","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度までの患者さんとご家族","TAUVID","アスマーク","The Link Group","2025-01-20"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","患者","","8","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度まで","TAUVID","アスマーク","The Link Group","2025-01-21"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","Dyad","定性","患者","","6","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度までの患者さんとご家族","TAUVID","アスマーク","The Link Group","2025-01-22"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","Dyad","定性","介護者","","6","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度までの患者さんとご家族","TAUVID","アスマーク","The Link Group","2025-01-23"
"アトピー性皮膚炎","Atopic Dermatitis, AD","IDI","定性","医師","皮膚科","8","疾患を問わず月平均の患者数が50人以上、アトピー性皮膚炎の成人患者が5名以上、生物学的製剤／新規経口全身製剤の処方箋が4枚以上","レブリキズマブ,イブグリース","キャンドゥ","The Link Group","2025-01-24"
"2型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","患者","","12","過去6ヶ月から15年以内に2型糖尿病と診断され、A1cが7以上で、主治医からA1cをコントロールできていないと言われている患者","GLP-1","アスマーク","The Link Group","2025-01-25"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","神経内科","3","1ヶ月にかかりつけ医は250人以上、専門医は100人以上を診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2025-01-26"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","脳神経外科","2","1ヶ月にかかりつけ医は250人以上、専門医は100人以上を診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2025-01-27"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","精神科","3","1ヶ月にかかりつけ医は250人以上、専門医は100人以上を診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2025-01-28"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","内科","3","1ヶ月にかかりつけ医は250人以上、専門医は100人以上を診療","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2025-01-29"
"関節リウマチ","Rheumatoid Arthritis","IDI","定性","医師","リウマチ科","9","1ヶ月に関節リウマチ患者を10人以上診療","バリシチニブ,オルミエント","キャンドゥ","The Link Group","2025-01-30"
"関節リウマチ","Rheumatoid Arthritis","IDI","定性","医師","整形外科","3","1ヶ月に関節リウマチ患者を10人以上診療","バリシチニブ,オルミエント","キャンドゥ","The Link Group","2025-01-31"
"動脈硬化性心疾患","Atherosclerotic Cardiovascular Disease, ASCVD","IDI","定性","医師","循環器内科","5","1ヶ月に脂質異常症／動脈硬化性心血管疾患患者を心臓・循環器専門医は30人以上、一般開業医は20人以上診療","PCSK-9 阻害薬","キャンドゥ","The Link Group","2025-02-01"
"動脈硬化性心疾患","Atherosclerotic Cardiovascular Disease, ASCVD","IDI","定性","医師","内科","2","1ヶ月に脂質異常症／動脈硬化性心血管疾患患者を心臓・循環器専門医は30人以上、一般開業医は20人以上診療","PCSK-9 阻害薬","キャンドゥ","The Link Group","2025-02-02"
"動脈硬化性心疾患","Atherosclerotic Cardiovascular Disease, ASCVD","IDI","定性","医師","総合診療科","1","1ヶ月に脂質異常症／動脈硬化性心血管疾患患者を心臓・循環器専門医は30人以上、一般開業医は20人以上診療","PCSK-9 阻害薬","キャンドゥ","The Link Group","2025-02-03"
"アトピー性皮膚炎","Atopic Dermatitis, AD","IDI","定性","医師","皮膚科","8","疾患を問わず月平均の患者数が50人以上、アトピー性皮膚炎の成人患者が5名以上、生物学的製剤／新規経口全身製剤の処方箋が4枚以上","レブリキズマブ,イブグリース","キャンドゥ","The Link Group","2025-02-04"
"アトピー性皮膚炎","Atopic Dermatitis, AD","IDI","定性","医師","皮膚科","12","1ヶ月に成人アトピー性皮膚炎・湿疹患者を20人以上診療、過去３ヶ月のJAK阻害剤処方箋数：病院勤務は10枚以上、クリニック勤務は5枚以上","バリシチニブ,オルミエント","キャンドゥ","The Link Group","2025-02-05"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","一般内科","2","1ヶ月に250人以上を診療し、そのうちアルツハイマー型認知症が疑われる軽度認知障害と軽度アルツハイマー型認知症患者の合計が5人以上","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2025-02-06"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","神経内科","1","1ヶ月に100人以上を診療し、そのうちアルツハイマー型認知症が疑われる軽度認知障害と軽度アルツハイマー型認知症患者の合計が10人以上","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2025-02-07"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","精神科","1","1ヶ月に100人以上を診療し、そのうちアルツハイマー型認知症が疑われる軽度認知障害と軽度アルツハイマー型認知症患者の合計が10人以上","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2025-02-08"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","脳神経外科","2","1ヶ月に100人以上を診療し、そのうちアルツハイマー型認知症が疑われる軽度認知障害と軽度アルツハイマー型認知症患者の合計が10人以上","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2025-02-09"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","内科","3","1ヶ月に250人以上を診療し、そのうちアルツハイマー型認知症が疑われる軽度認知障害と軽度アルツハイマー型認知症患者の合計が10人以上","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2025-02-10"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","精神科","2","1ヶ月に100人以上を診療し、そのうちアルツハイマー型認知症が疑われる軽度認知障害と軽度アルツハイマー型認知症患者の合計が20人以上","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2025-02-11"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","医師","神経内科","1","1ヶ月に100人以上を診療し、そのうちアルツハイマー型認知症が疑われる軽度認知障害と軽度アルツハイマー型認知症患者の合計が20人以上","ドナネマブ,ケサンラ","キャンドゥ","The Link Group","2025-02-12"
"肥満症","Obesity","IDI","定性","患者","","10","BMIが27以上、過去に減量経験がある、体重と将来の健康を心配している、体重減少をもたらす処方箋の減量薬服用を検討する","GLP-1","アスマーク","The Link Group","2025-02-13"
"犬猫用抗生剤","Veterinary antibacterial agents for dogs and cats","IDI","定性","医師","コンパニオンアニマル獣医","10","主に犬猫などの小動物を治療、一般医または総合医の獣医師免許資格を保有し、個人経営の動物病院で獣医師として従事","コンベニア","","The Link Group","2025-02-14"
"片頭痛","Migraine","IDI","定性","医師","神経学","3","１ヶ月に片頭痛患者を10人以上診療し、予防薬で治療している患者の割合が20%以上、過去３ヶ月に処方したカルシトニン遺伝子関連ペプチド（CGRP）モノクローナル抗体が５件以上","エムガルティ,ガルカネズマブ","キャンドゥ","The Link Group","2025-02-15"
"片頭痛","Migraine","IDI","定性","医師","脳神経外科","2","１ヶ月に片頭痛患者を10人以上診療し、予防薬で治療している患者の割合が20%以上、過去３ヶ月に処方したカルシトニン遺伝子関連ペプチド（CGRP）モノクローナル抗体が５件以上","エムガルティ,ガルカネズマブ","キャンドゥ","The Link Group","2025-02-16"
"片頭痛","Migraine","IDI","定性","医師","内科","2","１ヶ月に片頭痛患者を10人以上診療し、予防薬で治療している患者の割合が20%以上、過去３ヶ月に処方したカルシトニン遺伝子関連ペプチド（CGRP）モノクローナル抗体が５件以上","エムガルティ,ガルカネズマブ","キャンドゥ（日経）","The Link Group","2025-02-17"
"片頭痛","Migraine","IDI","定性","医師","精神科","2","１ヶ月に片頭痛患者を10人以上診療し、予防薬で治療している患者の割合が20%以上、過去３ヶ月に処方したカルシトニン遺伝子関連ペプチド（CGRP）モノクローナル抗体が５件以上","エムガルティ,ガルカネズマブ","キャンドゥ（日経）","The Link Group","2025-02-18"
"片頭痛","Migraine","IDI","定性","医師","神経学","1","１ヶ月に片頭痛患者を10人以上診療し、予防薬で治療している患者の割合が20%以上、過去３ヶ月に処方したカルシトニン遺伝子関連ペプチド（CGRP）モノクローナル抗体が５件以上","エムガルティ,ガルカネズマブ","キャンドゥ（日経）","The Link Group","2025-02-19"
"片頭痛","Migraine","IDI","定性","医師","内科","3","１ヶ月に片頭痛患者を10人以上診療し、予防薬で治療している患者の割合が20%以上、過去３ヶ月に処方したカルシトニン遺伝子関連ペプチド（CGRP）モノクローナル抗体が５件以上","エムガルティ,ガルカネズマブ","キャンドゥ（日経）","The Link Group","2025-02-20"
"片頭痛","Migraine","IDI","定性","医師","脳神経外科","3","１ヶ月に片頭痛患者を10人以上診療し、予防薬で治療している患者の割合が20%以上、過去３ヶ月に処方したカルシトニン遺伝子関連ペプチド（CGRP）モノクローナル抗体が５件以上","エムガルティ,ガルカネズマブ","キャンドゥ（日経）","The Link Group","2025-02-21"
"片頭痛","Migraine","IDI","定性","医師","神経学","3","１ヶ月に片頭痛患者を10人以上診療し、予防薬で治療している患者の割合が20%以上、過去３ヶ月に処方したカルシトニン遺伝子関連ペプチド（CGRP）モノクローナル抗体が５件以上","エムガルティ,ガルカネズマブ","キャンドゥ（日経）","The Link Group","2025-02-22"
"片頭痛","Migraine","IDI","定性","医師","精神科","2","１ヶ月に片頭痛患者を10人以上診療し、予防薬で治療している患者の割合が20%以上、過去３ヶ月に処方したカルシトニン遺伝子関連ペプチド（CGRP）モノクローナル抗体が５件以上","エムガルティ,ガルカネズマブ","キャンドゥ（日経）","The Link Group","2025-02-23"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","医師","泌尿器科","8","過去3ヶ月に去勢抵抗性前立腺がん患者、ホルモン感受性前立腺がん患者をそれぞれ１名以上治療、転移性ホルモン感受性前立腺がん患者が5名以上","アベマシクリブ,ベージニオ","キャンドゥ","The Link Group","2025-02-24"
"非小細胞肺がん","Non-Small Cell Lung Cance, NSCLC","IDI","定性","医師","腫瘍内科","2","1ヶ月に15人以上の非小細胞肺がん患者を治療し、そのうち７人以上が転移性非小細胞肺がん","","キャンドゥ","The Link Group","2025-02-25"
"非小細胞肺がん","Non-Small Cell Lung Cance, NSCLC","IDI","定性","医師","呼吸器外科","2","1ヶ月に15人以上の非小細胞肺がん患者を治療し、そのうち７人以上が転移性非小細胞肺がん","","キャンドゥ","The Link Group","2025-02-26"
"非小細胞肺がん","Non-Small Cell Lung Cance, NSCLC","IDI","定性","医師","呼吸器科","6","1ヶ月に15人以上の非小細胞肺がん患者を治療し、そのうち７人以上が転移性非小細胞肺がん","","キャンドゥ","The Link Group","2025-02-27"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","医師","泌尿器科","8","過去1ヶ月に治療した去勢抵抗性前立腺がん患者の5名以上が転移性がん","アベマシクリブ,ベージニオ","キャンドゥ","The Link Group","2025-02-28"
"肥満症","Obesity","IDI","定性","医師","整形外科","1","1ヶ月に20人以上の肥満症患者を診療","GLP-1","キャンドゥ","The Link Group","2025-03-01"
"肥満症","Obesity","IDI","定性","医師","循環器内科","1","1ヶ月に20人以上の肥満症患者を診療","GLP-1","キャンドゥ","The Link Group","2025-03-02"
"肥満症","Obesity","IDI","定性","医師","産婦人科","1","1ヶ月に20人以上の肥満症患者を診療","GLP-1","キャンドゥ","The Link Group","2025-03-03"
"肥満症","Obesity","IDI","定性","医師","消化器内科","1","1ヶ月に20人以上の肥満症患者を診療","GLP-1","キャンドゥ","The Link Group","2025-03-04"
"肥満症","Obesity","IDI","定性","医師","内科","4","1ヶ月に20人以上の肥満症患者を診療","GLP-1","キャンドゥ","The Link Group","2025-03-05"
"肥満症","Obesity","IDI","定性","医師","内分泌・代謝内科","1","1ヶ月に20人以上の肥満症患者を診療","GLP-1","キャンドゥ","The Link Group","2025-03-06"
"肥満症","Obesity","IDI","定性","医師","腎臓内科","1","1ヶ月に20人以上の肥満症患者を診療","GLP-1","キャンドゥ","The Link Group","2025-03-07"
"肥満症","Obesity","IDI","定性","医師","総合診療科","2","1ヶ月に20人以上の肥満症患者を診療","GLP-1","キャンドゥ","The Link Group","2025-03-08"
"2型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","医師","糖尿病内科","8","1ヶ月に100人以上の成人の2型糖尿病患者を診療、過去３ヶ月に10名以上にGLP-1を処方している","GLP-1","キャンドゥ","The Link Group","2025-03-09"
"2型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","医師","一般内科","6","1ヶ月に50人以上の成人の2型糖尿病患者を診療、過去３ヶ月に10名以上にGLP-1を処方している","GLP-1","キャンドゥ","The Link Group","2025-03-10"
"2型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","医師","総合診療科","1","1ヶ月に50人以上の成人の2型糖尿病患者を診療、過去３ヶ月に10名以上にGLP-1を処方している","GLP-1","キャンドゥ","The Link Group","2025-03-11"
"全身性エリテマトーデス/関節リウマチ","Systemic Lupus Erythematosus, SLE/Rheumatoid Arthritis, RA","IDI","定性","医師","リウマチ科","14","1ヶ月に診療する関節リウマチ患者が40人以上、全身性エリテマトーデス患者が15人以上、過去1ヶ月に関節リウマチに生物学的製剤／JAK阻害剤の処方箋を10枚以上処方","","キャンドゥ","The Link Group","2025-03-12"
"2型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","患者","","10","過去6ヶ月から15年以内に2型糖尿病と診断され、直近のA1c値が7以上ある、現在経口薬、インスリン以外の注射、または基礎インスリンで治療中、今後注射薬を使用する可能性がある","GLP-1","アスマーク","The Link Group","2025-03-13"
"急性骨髄性白血病/胆管細胞がん","Acute Myeloid Leukemia, AML/Cholangiocarcinoma, CCA","IDI","定性","医師","肝胆膵外科/内科 （消化器外科・内科を含む）","7","過去3ヶ月に急性骨髄性白血病患者を10人以上、肝・胆道がん患者を2人以上、肝内胆管がんと肝外胆管がん患者を合計で1人以上診療","","キャンドゥ","The Link Group","2025-03-14"
"急性骨髄性白血病/胆管細胞がん","Acute Myeloid Leukemia, AML/Cholangiocarcinoma, CCA","IDI","定性","医師","血液科/血液腫瘍科","13","過去3ヶ月に急性骨髄性白血病患者を10人以上、肝・胆道がん患者を2人以上、肝内胆管がんと肝外胆管がん患者を合計で1人以上診療","","キャンドゥ","The Link Group","2025-03-15"
"急性骨髄性白血病/胆管細胞がん","Acute Myeloid Leukemia, AML/Cholangiocarcinoma, CCA","IDI","定性","医師","腫瘍内科","2","過去3ヶ月に急性骨髄性白血病患者を10人以上、肝・胆道がん患者を2人以上、肝内胆管がんと肝外胆管がん患者を合計で1人以上診療","","キャンドゥ","The Link Group","2025-03-16"
"腹膜透析","Peritoneal Dialysis, PD","IDI","定性","医師","腎臓内科","6","自身で管理している透析患者が10人以上、腹膜透析が5人以上","","キャンドゥ","The Link Group","2025-03-17"
"腹膜透析","Peritoneal Dialysis, PD","IDI","定性","患者","","3","腹膜透析を6ヵ月以上実施している","","SNS","The Link Group","2025-03-18"
"糖尿病","Diabetes","IDI","定性","医師","糖尿病科","6","1ヶ月に糖尿病患者（1型2型どちらでも）を一般内科医は50人以上、内分泌科/ 糖尿病科: 80人以上診療","","キャンドゥ","The Link Group","2025-03-19"
"糖尿病","Diabetes","IDI","定性","医師","内科","1","1ヶ月に糖尿病患者（1型2型どちらでも）を一般内科医は50人以上、内分泌科/ 糖尿病科: 80人以上診療","","キャンドゥ","The Link Group","2025-03-20"
"糖尿病","Diabetes","IDI","定性","医師","かかりつけ医・一般内科","1","1ヶ月に糖尿病患者（1型2型どちらでも）を一般内科医は50人以上、内分泌科/ 糖尿病科: 80人以上診療","","キャンドゥ","The Link Group","2025-03-21"
"アトピー性皮膚炎","Atopic Dermatitis","IDI","定性","医師","皮膚科医","30","1ヶ月に50人以上の患者を診療","","キャンドゥ","The Link Group","2025-03-22"
"脂質異常症","PAD","IDI","定性","医師","血管外科・心臓血管外科","3","1ヶ月に脂質異常症患者を30人以上、末梢動脈疾患患者を10人以上診療","","キャンドゥ","The Link Group","2025-03-23"
"脂質異常症","PAD","IDI","定性","医師","循環器内科","5","1ヶ月に脂質異常症患者を30人以上、末梢動脈疾患患者を10人以上診療","","キャンドゥ","The Link Group","2025-03-24"
"乳がん","Breast cancer","IDI","定性","医師","腫瘍内科","3","ホルモン受容体陽性HER2陰性 (HR陽性HER2陰性) の乳癌患者のうち、過去3ヶ月間に診療したステージ4の患者が10人以上","","キャンドゥ","The Link Group","2025-03-25"
"乳がん","Breast cancer","IDI","定性","医師","乳腺外科・内分泌外科","9","ホルモン受容体陽性HER2陰性 (HR陽性HER2陰性) の乳癌患者のうち、過去3ヶ月間に診療したステージ4の患者が10人以上","","キャンドゥ","The Link Group","2025-03-26"
"慢性腎不全","Chronic Kidney Disease, CKD","IDI","定性","医師","循環器内科・心臓外科","9","1ヶ月に30人以上の腎機能障害患者を診療する腎臓内科医、または、心不全（すべてのタイプ）の患者を月に30人以上診療する循環器専門医","","キャンドゥ","The Link Group","2025-03-27"
"慢性腎不全","Chronic Kidney Disease, CKD","IDI","定性","医師","腎臓内科","11","1ヶ月に30人以上の腎機能障害患者を診療する腎臓内科医、または、心不全（すべてのタイプ）の患者を月に30人以上診療する循環器専門医","","キャンドゥ","The Link Group","2025-03-28"
"肥満症","Obesity","IDI","定性","医師","糖尿病科","3","1ヶ月に100人以上の成人患者（18歳以上）を診療","","キャンドゥ","The Link Group","2025-03-29"
"肥満症","Obesity","IDI","定性","医師","一般内科","2","1ヶ月に100人以上の成人患者（18歳以上）を診療","","キャンドゥ","The Link Group","2025-03-30"
"肥満症","Obesity","IDI","定性","医師","産婦人科・婦人科","2","1ヶ月に100人以上の成人患者（18歳以上）を診療","","キャンドゥ","The Link Group","2025-03-31"
"肥満症","Obesity","IDI","定性","医師","消化器科","3","1ヶ月に100人以上の成人患者（18歳以上）を診療","","キャンドゥ","The Link Group","2025-04-01"
"2型糖尿病","T2D","IDI","定性","患者","","10","年齢25～70歳で6ヶ月より前に2型糖尿病と診断された","","アスマーク","Escalent","2025-04-02"
"プレクリニカルアルツハイマー病","Preclinical Alzheimer’s Disease","IDI","定性","患者","","11","55～80歳の前臨床と分類され認知機能低下の徴候や症状がなく記憶力／思考力の健康に関する検査や薬物療法に前向きでアルツハイマーの家族歴がある ","","アスマーク","Escalent","2025-04-03"
"2型糖尿病","T2D","IDI","定性","患者","","10","25～70歳で6ヶ月より前に2型糖尿病と診断され現在注射薬を使用しておらず基礎インスリンまたは食事前に投与するインスリンを使用したことがない 患者","","アスマーク","Escalent","2025-04-04"
"肥満症","Obesity","IDI","定性","患者","","12","18~79歳で自分の体重が将来の健康に影響を与える可能性を多少～非常に心配しているBMI 27-39.9、かつ肥満症関連疾患(ORC)がある人","","アスマーク","Escalent","2025-04-05"
"肥満症","Obesity","IDI","定性","医師","内科","1","一ヶ月に糖尿病と診断されていない肥満症、または減量目的の患者を内分泌代謝科専門医と糖尿病専門医で30人以上、かかりつけ医と循環器内科医で15人以上診療","","キャンドゥ","Escalent","2025-04-06"
"肥満症","Obesity","IDI","定性","医師","循環器内科","2","一ヶ月に糖尿病と診断されていない肥満症、または減量目的の患者を内分泌代謝科専門医と糖尿病専門医で30人以上、かかりつけ医と循環器内科医で15人以上診療","","キャンドゥ","Escalent","2025-04-07"
"肥満症","Obesity","IDI","定性","医師","糖尿病専門医","3","一ヶ月に糖尿病と診断されていない肥満症、または減量目的の患者を内分泌代謝科専門医と糖尿病専門医で30人以上、かかりつけ医と循環器内科医で15人以上診療","","キャンドゥ","Escalent","2025-04-08"
"肥満症","Obesity","IDI","定性","医師","内分泌代謝専門医","3","一ヶ月に糖尿病と診断されていない肥満症、または減量目的の患者を内分泌代謝科専門医と糖尿病専門医で30人以上、かかりつけ医と循環器内科医で15人以上診療","","キャンドゥ","Escalent","2025-04-09"
"肥満症","Obesity","IDI","定性","医師","総合診療医/かかりつけ医(一般診療医)/プライマリケア医","2","一ヶ月に糖尿病と診断されていない肥満症、または減量目的の患者を内分泌代謝科専門医と糖尿病専門医で30人以上、かかりつけ医と循環器内科医で15人以上診療","","キャンドゥ","Escalent","2025-04-10"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/MCI","IDI","定性","患者","","4","60~75歳で記憶力と思考力のための薬物療法に少なくとも「ある程度」前向きである MCIまたは軽度ADと診断されている過去2年間に医師を受診した患者","","アスマーク","Escalent","2025-04-11"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/MCI","IDI","定性","患者","","3","55~80歳でアルツハイマー型認知症または軽度認知障害と診断されている","","アスマーク","Escalent","2025-04-12"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","患者","","12","40～75歳で転移性前立腺がんと診断されている","","アスマーク/3Hメディソリューション","Escalent","2025-04-13"
"肥満症","Obesity","IDI","定性","医師","","12","１ヶ月に肥満症患者を25人以上診療","","キャンドゥ","Escalent","2025-04-14"
"尋常性乾癬","Plaque psoriasis","IDI","定性","医師","皮膚科","8","1ヶ月に40人以上の尋常性乾癬患者を診療","","","Escalent","2025-04-15"
"腫瘍","Tumor","IDI","定性","医師","腫瘍内科","3","過去１ヶ月に膵癌治療医は７人以上の膵癌患を、大腸癌治療は、2人以上の大腸癌患者を、卵巣癌治療医は、4人以上の卵巣癌患者を、肉腫治療医は、2人以上の肉腫患者を診療","","キャンドゥ","Escalent","2025-04-16"
"腫瘍","Tumor","IDI","定性","医師","婦人科","4","過去１ヶ月に膵癌治療医は７人以上の膵癌患を、大腸癌治療は、2人以上の大腸癌患者を、卵巣癌治療医は、4人以上の卵巣癌患者を、肉腫治療医は、2人以上の肉腫患者を診療","","キャンドゥ","Escalent","2025-04-17"
"腫瘍","Tumor","IDI","定性","医師","肝胆膵外科/内科","1","過去１ヶ月に膵癌治療医は７人以上の膵癌患を、大腸癌治療は、2人以上の大腸癌患者を、卵巣癌治療医は、4人以上の卵巣癌患者を、肉腫治療医は、2人以上の肉腫患者を診療","","キャンドゥ","Escalent","2025-04-18"
"腫瘍","Tumor","IDI","定性","医師","整形外科","2","過去１ヶ月に膵癌治療医は７人以上の膵癌患を、大腸癌治療は、2人以上の大腸癌患者を、卵巣癌治療医は、4人以上の卵巣癌患者を、肉腫治療医は、2人以上の肉腫患者を診療","","キャンドゥ","Escalent","2025-04-19"
"腫瘍","Tumor","IDI","定性","医師","消化器外科/内科","3","過去１ヶ月に膵癌治療医は７人以上の膵癌患を、大腸癌治療は、2人以上の大腸癌患者を、卵巣癌治療医は、4人以上の卵巣癌患者を、肉腫治療医は、2人以上の肉腫患者を診療","","キャンドゥ","Escalent","2025-04-20"
"腫瘍","Tumor","IDI","定性","医師","血液・腫瘍内科","1","過去１ヶ月に膵癌治療医は７人以上の膵癌患を、大腸癌治療は、2人以上の大腸癌患者を、卵巣癌治療医は、4人以上の卵巣癌患者を、肉腫治療医は、2人以上の肉腫患者を診療","","キャンドゥ","Escalent","2025-04-21"
"軽度外傷性脳損","mTB","IDI","定性","KOL","脳神経外科講師 外傷斑責任者","1","様々な超急性状況におけるmTBI（軽度外傷性脳損傷）の発生、プロトコル開発、初期評価に重点的に取り組むmTBI／脳震盪の専門家 ","","キャンドゥ","Escalent","2025-04-22"
"軽度外傷性脳損","mTB","IDI","定性","KOL","外傷診療科	科長","1","様々な超急性状況におけるmTBI（軽度外傷性脳損傷）の発生、プロトコル開発、初期評価に重点的に取り組むmTBI／脳震盪の専門家 ","","キャンドゥ","Escalent","2025-04-23"
"軽度外傷性脳損","mTB","IDI","定性","KOL","スポーツ医学を教えている教授","1","様々な超急性状況におけるmTBI（軽度外傷性脳損傷）の発生、プロトコル開発、初期評価に重点的に取り組むmTBI／脳震盪の専門家 ","","キャンドゥ","Escalent","2025-04-24"
"軽度外傷性脳損","mTB","IDI","定性","KOL","調査研究を実施する研究員","1","様々な超急性状況におけるmTBI（軽度外傷性脳損傷）の発生、プロトコル開発、初期評価に重点的に取り組むmTBI／脳震盪の専門家 ","","キャンドゥ","Escalent","2025-04-25"
"腫瘍","Tumor","IDI","定性","医師","大腸外科/下部消化器外科","4","過去１ヶ月に膵癌治療医は７人以上の膵癌患を、大腸癌治療は、2人以上の大腸癌患者を、卵巣癌治療医は、4人以上の卵巣癌患者を、肉腫治療医は、2人以上の肉腫患者を診療","","キャンドゥ","Escalent","2025-04-26"
"腫瘍","Tumor","IDI","定性","医師","婦人科","12","過去１ヶ月に膵癌治療医は７人以上の膵癌患を、大腸癌治療は、2人以上の大腸癌患者を、卵巣癌治療医は、4人以上の卵巣癌患者を、肉腫治療医は、2人以上の肉腫患者を診療","","キャンドゥ","Escalent","2025-04-27"
"腫瘍","Tumor","IDI","定性","医師","消化器外科/内科","13","過去１ヶ月に膵癌治療医は７人以上の膵癌患を、大腸癌治療は、2人以上の大腸癌患者を、卵巣癌治療医は、4人以上の卵巣癌患者を、肉腫治療医は、2人以上の肉腫患者を診療","","キャンドゥ","Escalent","2025-04-28"
"腫瘍","Tumor","IDI","定性","医師","腫瘍内科","8","過去１ヶ月に膵癌治療医は７人以上の膵癌患を、大腸癌治療は、2人以上の大腸癌患者を、卵巣癌治療医は、4人以上の卵巣癌患者を、肉腫治療医は、2人以上の肉腫患者を診療","","キャンドゥ","Escalent","2025-04-29"
"腫瘍","Tumor","IDI","定性","医師","整形外科","5","過去１ヶ月に膵癌治療医は７人以上の膵癌患を、大腸癌治療は、2人以上の大腸癌患者を、卵巣癌治療医は、4人以上の卵巣癌患者を、肉腫治療医は、2人以上の肉腫患者を診療","","キャンドゥ","Escalent","2025-04-30"
"腫瘍","Tumor","IDI","定性","医師","肝胆膵外科/内科","3","過去１ヶ月に膵癌治療医は７人以上の膵癌患を、大腸癌治療は、2人以上の大腸癌患者を、卵巣癌治療医は、4人以上の卵巣癌患者を、肉腫治療医は、2人以上の肉腫患者を診療","","キャンドゥ","Escalent","2025-05-01"
"腫瘍","Tumor","IDI","定性","医師","腫瘍外科","2","過去１ヶ月に膵癌治療医は７人以上の膵癌患を、大腸癌治療は、2人以上の大腸癌患者を、卵巣癌治療医は、4人以上の卵巣癌患者を、肉腫治療医は、2人以上の肉腫患者を診療","","キャンドゥ","Escalent","2025-05-02"
"肥満症","Obesity","IDI","定性","患者","","15","20~66歳でBMI24以上","","アスマーク","Escalent","2025-05-03"
"慢性炎症性脱髄性多発根神経炎																																							","CIDP","IDI","定性","患者","","6","18～75歳 でCIDPと診断されてから1年以上経過しており診断にあたり神経電動検査を受けている。過去６ヶ月以上に専門医を受診し、現在、CIDP治療に処方薬を服用／使用中。CIDPにより、日常生活に影響がある(多少～著しい影響）患者																	","","3Hメディソリューションズ/キャンドゥ","Fieldcats","2025-05-04"
"慢性炎症性脱髄性多発根神経炎																																							","CIDP","IDI","定性","看護師","","4","過去12ヶ月間に管理/診療した成人CIDP患者数 が５人以上","","3Hメディソリューションズ/キャンドゥ","Fieldcats","2025-05-05"
"慢性炎症性脱髄性多発根神経炎																																							","CIDP","IDI","定性","医師","脳神経内科","14","過去12ヶ月間に管理/診療した成人CIDP患者数 が５人以上","","3Hメディソリューションズ/キャンドゥ","Fieldcats","2025-05-06"
"慢性炎症性脱髄性多発根神経炎																																							","CIDP","IDI","定性","医師","末梢神経障害専門","3","過去12ヶ月間に管理/診療した成人CIDP患者数 が５人以上","","3Hメディソリューションズ/キャンドゥ","Fieldcats","2025-05-07"
"ナルコレプシー","Narcolepsy","IDI","定性","患者","","5","18歳以上のナルコレプシーと診断された患者","","3Hメディソリューションズ","Fieldcats","2025-05-08"
"肥満症","Obesity","IDI","定性","患者","","10","18歳以上の高度肥満症または肥満症を有する成人","","アスマーク","Fieldcats","2025-05-09"
"局所進行性切除不能膵がん																																				","Locally advanced unresectable pancreatic cancer","IDI","定性","医師","腫瘍内科","4","過去12ヶ月に膵臓がん患者を10人以上診療","","3Hメディソリューションズ/キャンドゥ","Fieldcats","2025-05-10"
"局所進行性切除不能膵がん																																				","Locally advanced unresectable pancreatic cancer","IDI","定性","医師","消化器外科","1","過去12ヶ月に膵臓がん患者を10人以上診療","","3Hメディソリューションズ/キャンドゥ","Fieldcats","2025-05-11"
"局所進行性切除不能膵がん																																				","Locally advanced unresectable pancreatic cancer","IDI","定性","医師","消化器内科","1","過去12ヶ月に膵臓がん患者を10人以上診療","","3Hメディソリューションズ/キャンドゥ","Fieldcats","2025-05-12"
"局所進行性切除不能膵がん																																				","Locally advanced unresectable pancreatic cancer","IDI","定性","医師","放射線科","2","過去12ヶ月に膵臓がん患者を10人以上診療","","3Hメディソリューションズ/キャンドゥ","Fieldcats","2025-05-13"
"局所進行性切除不能膵がん																																				","Locally advanced unresectable pancreatic cancer","IDI","定性","患者","","4","18～75歳で局所進行、切除不能、転移なし の膵臓がんと診断された患者またはその介護者","","3Hメディソリューションズ/キャンドゥ","Fieldcats","2025-05-14"
"慢性閉塞性肺疾患","COPD","IDI","定性","患者","","11","40～85歳で慢性閉塞性肺疾患(COPD)、慢性気管支炎、肺気腫と診断され、現在治療薬を使用/服用している患者	または、患者を介護している18歳以上の介護者																	","","3Hメディソリューションズ","Fieldcats","2025-05-15"
"慢性閉塞性肺疾患","COPD","IDI","定性","介護者","","3","40～85歳で慢性閉塞性肺疾患(COPD)、慢性気管支炎、肺気腫と診断され、現在治療薬を使用/服用している患者	または、患者を介護している18歳以上の介護者																	","","3Hメディソリューションズ","Fieldcats","2025-05-16"
"雇用機会","Employment opportunities","IDI","定性","その他（求職者）","","4","18～64歳までの生まれてからずっと日本に居住しており年収が960万円未満の人","","アスマーク","Fieldcats","2025-05-17"
"非閉塞性肥大型心筋症																																						","nHCM","IDI","定性","医師","循環器科","12","過去12ヶ月に非閉塞性肥大型心筋症患者を5人以上診療","","キャンドゥ","Fieldcats","2025-05-18"
"潰瘍性大腸炎","Ulcerative Colitis","IDI","定性","患者","","","18歳以上で過去10年以内に潰瘍性大腸炎と診断された患者","","3Hメディソリューションズ","Fieldcats","2025-05-19"
"非閉塞性肥大型心筋症																																						","nHCM","IDI","定性","患者","","1","18歳以上で肥大型心筋症(HCM)／家族性肥大型心筋症 と診断されている","","3Hメディソリューションズ/キャンドゥ/アスマーク","Fieldcats","2025-05-20"
"非閉塞性肥大型心筋症																																						","nHCM","IDI","定性","医師","循環器内科","10","過去12ヶ月に非閉塞性肥大型心筋症患者を循環器科医は15人以上、かかりつけ医は1人以上診療","","3Hメディソリューションズ/キャンドゥ/アスマーク","Fieldcats","2025-05-21"
"非閉塞性肥大型心筋症																																						","nHCM","IDI","定性","医師","かかりつけ医","1","過去12ヶ月に非閉塞性肥大型心筋症患者を循環器科医は15人以上、かかりつけ医は1人以上診療","","3Hメディソリューションズ/キャンドゥ/アスマーク","Fieldcats","2025-05-22"
"潰瘍性大腸炎","Ulcerative Colitis","IDI","定性","医師","消化器内科","10","過去3ヶ月に中等度と重度合わせて25人以上の潰瘍性大腸炎患者を診療","","キャンドゥ","Fieldcats","2025-05-23"
"がん4種","The four major types of Tumor/Cancer ","IDI","定性","医師","放射線科/放射線腫瘍科","12","過去12ヵ月以内に、膠芽腫患者を5人以上、または、非小細胞肺がん 患者を20人以上、または卵巣がん患者を10人以上、または膵臓がん患者を10人以上診療","","キャンドゥ","Fieldcats","2025-05-24"
"がん4種","The four major types of Tumor/Cancer ","IDI","定性","医師","脳神経外科","2","過去12ヵ月以内に、膠芽腫患者を5人以上、または、非小細胞肺がん 患者を20人以上、または卵巣がん患者を10人以上、または膵臓がん患者を10人以上診療","","キャンドゥ","Fieldcats","2025-05-25"
"がん4種","The four major types of Tumor/Cancer ","IDI","定性","医師","呼吸器内科","1","過去12ヵ月以内に、膠芽腫患者を5人以上、または、非小細胞肺がん 患者を20人以上、または卵巣がん患者を10人以上、または膵臓がん患者を10人以上診療","","キャンドゥ","Fieldcats","2025-05-26"
"がん4種","The four major types of Tumor/Cancer ","IDI","定性","医師","呼吸器外科","1","過去12ヵ月以内に、膠芽腫患者を5人以上、または、非小細胞肺がん 患者を20人以上、または卵巣がん患者を10人以上、または膵臓がん患者を10人以上診療","","キャンドゥ","Fieldcats","2025-05-27"
"がん4種","The four major types of Tumor/Cancer ","IDI","定性","医師","婦人科/乳腺外科","2","過去12ヵ月以内に、膠芽腫患者を5人以上、または、非小細胞肺がん 患者を20人以上、または卵巣がん患者を10人以上、または膵臓がん患者を10人以上診療","","キャンドゥ","Fieldcats","2025-05-28"
"急性骨髄性白血病","AML","Webアンケート","定量","医師","血液腫瘍内科","54","過去6ヶ月にAML患者を６人以上診療","","日経BP","Holden","2025-05-29"
"IgA腎症","IgA nephropathy, IgAN","IDI","定性","医師","腎臓内科","15","過去12ヶ月にIgA腎症患者を8人以上診療","","キャンドゥ","Holden","2025-05-30"
"局所進行結腸がん ","Locally advanced colon cancer","IDI","定性","患者","","6","18～75歳の結腸がんと診断された抗がん剤治療と手術を受けた患者","","3Hメディソリューションズ","Holden","2025-05-31"
"局所進行結腸がん ","Locally advanced colon cancer","IDI","定性","介護者","","1","18～75歳の結腸がんと診断された抗がん剤治療と手術を受けた患者の介護者","","3Hメディソリューションズ","Holden","2025-06-01"
"局所進行結腸がん ","Locally advanced colon cancer","IDI","定性","医師","放射線科","3","過去6ヶ月に結腸癌患者を腫瘍内科医/ 消化器腫瘍内科医 / 外科医は30人以上、消化器内科医/ 病理医は5人以上診療","","キャンドゥ","Holden","2025-06-02"
"局所進行結腸がん ","Locally advanced colon cancer","IDI","定性","医師","消化器内科・外科","2","過去6ヶ月に結腸癌患者を腫瘍内科医/ 消化器腫瘍内科医 / 外科医は30人以上、消化器内科医/ 病理医は5人以上診療","","キャンドゥ","Holden","2025-06-03"
"多発性骨髄腫","Multiple myeloma","Webアンケート","定量","医師","血液内科、腫瘍内科、内科","20","一年間に症候性の多発性骨髄腫患者を6人以上診療","","日経BP","Holden","2025-06-04"
"甲状腺関連眼疾患","Thyroid Eye Disease","Webアンケート","定量","医師","内分泌専門医/甲状腺専門医 ","20","過去6ヶ月に、甲状腺眼症 、バセドウ病眼症 、甲状腺関連眼症 患者を内分泌専門医、眼科医は4人以上診療、","","日経BP","Holden","2025-06-05"
"甲状腺関連眼疾患","Thyroid Eye Disease","Webアンケート","定量","医師","眼科医 ","30","過去6ヶ月に、甲状腺眼症 、バセドウ病眼症 、甲状腺関連眼症 患者を内分泌専門医、眼科医は4人以上診療、","","日経BP","Holden","2025-06-06"
"脂肪肝","SLD","IDI","定性","医師","精神科","2","過去3ヶ月に脂肪肝患者を消化器専門医、肝胆膵専門医 は20人以上、かかりつけ医、内分泌科医、精神科医は10人以上診療","","キャンドゥ","Holden","2025-06-07"
"脂肪肝","SLD","IDI","定性","医師","一般内科医／総合診療医","1","過去3ヶ月に脂肪肝患者を消化器専門医、肝胆膵専門医 は20人以上、かかりつけ医、内分泌科医、精神科医は10人以上診療","","キャンドゥ","Holden","2025-06-08"
"脂肪肝","SLD","IDI","定性","医師","内分泌／代謝専門医","1","過去3ヶ月に脂肪肝患者を消化器専門医、肝胆膵専門医 は20人以上、かかりつけ医、内分泌科医、精神科医は10人以上診療","","キャンドゥ","Holden","2025-06-09"
"脂肪肝","SLD","IDI","定性","医師","肝臓専門医","2","過去3ヶ月に脂肪肝患者を消化器専門医、肝胆膵専門医 は20人以上、かかりつけ医、内分泌科医、精神科医は10人以上診療","","キャンドゥ","Holden","2025-06-10"
"変形性膝関節症","Knee osteoarthritis","IDI","定性","医師","整形外科","14","3ヶ月に診療する変形性膝関節症患者のうち疼痛を伴う中等度から重度の患者の割合が30％以上","","キャンドゥ","Holden","2025-06-11"
"膀胱がん","Bladder cancer","Webアンケート","定量","医師","泌尿器科","60","3ヶ月に膀胱がん/尿路上皮がんの成人患者を5人以上診療、切除不能な筋層浸潤性膀胱癌又は転移性膀胱/尿路上皮がん（mUC）患者が4人以上診療。","","日経BP","Holden","2025-06-12"
"シェーグレン症候群																																						","Sj?gren’s syndrome","IDI","定性","医師","リウマチ科","10","過去12ヵ月にシェーグレン症候群 (SjD) の患者を60人以上診療","","キャンドゥ","Holden","2025-06-13"
"多発性骨髄腫","Multiple myeloma","Webアンケート","定量","医師","腫瘍内科/血液内科/血液腫瘍内科","22","多発性骨髄腫（症候性多発性骨髄腫）患者を10人以上診療。","","日経BP","Holden","2025-06-14"
"転移性尿路上皮がん","Metastatic urothelial cancer","IDI","定性","医師","泌尿器科","8","過去3ヶ月に切除不能な局所進行性または転移性尿路上皮がんの患者数を3人以上診療","","キャンドゥ","Holden","2025-06-15"
"転移性胃腺がん／胃食道接合部腺がん","Metastatic gastric adenocarcinoma/Gastroesophageal junction adenocarcinoma","IDI","定性","医師","消化器腫瘍科","1","過去3ヶ月に胃がんと胃食道接合部 (GEJ) がん患者を30人以上診療","","キャンドゥ","Holden","2025-06-16"
"転移性胃腺がん／胃食道接合部腺がん","Metastatic gastric adenocarcinoma/Gastroesophageal junction adenocarcinoma","IDI","定性","医師","消化器内科","6","過去3ヶ月に胃がんと胃食道接合部 (GEJ) がん患者を30人以上診療","","キャンドゥ","Holden","2025-06-17"
"転移性胃腺がん／胃食道接合部腺がん","Metastatic gastric adenocarcinoma/Gastroesophageal junction adenocarcinoma","IDI","定性","医師","病理科","3","過去3ヶ月に胃がんと胃食道接合部 (GEJ) がん患者を30人以上診療","","キャンドゥ","Holden","2025-06-18"
"転移性胃腺がん／胃食道接合部腺がん","Metastatic gastric adenocarcinoma/Gastroesophageal junction adenocarcinoma","IDI","定性","医師","上部消化器外科","3","過去3ヶ月に胃がんと胃食道接合部 (GEJ) がん患者を30人以上診療","","キャンドゥ","Holden","2025-06-19"
"転移性胃腺がん／胃食道接合部腺がん","Metastatic gastric adenocarcinoma/Gastroesophageal junction adenocarcinoma","IDI","定性","医師","腫瘍内科","2","過去3ヶ月に胃がんと胃食道接合部 (GEJ) がん患者を30人以上診療","","キャンドゥ","Holden","2025-06-20"
"パーキンソン病","Parkinson’s disease","IDI","定性","医師","神経科","6","1ヶ月に特発性パーキンソン病 患者を10人以上診療","","キャンドゥ","Holden","2025-06-21"
"パーキンソン病","Parkinson’s disease","IDI","定性","医師","運動障害専門医","3","1ヶ月に特発性パーキンソン病 患者を10人以上診療","","キャンドゥ","Holden","2025-06-22"
"C3腎症","C3 Glomerulopathy, C3G","IDI","定性","医師","腎臓内科","1","過去12ヶ月でC3腎症患者を1人以上診療","","キャンドゥ","Holden","2025-06-23"
"COVID19予防薬","COVID-19 preventive medication","Webアンケート","定量","医師","","55","過去12ヶ月に診療した造血器悪性腫瘍患者と過去2年以内に造血幹細胞移植を受けた患者の合計が40人以上","","","","2025-06-24"
"乾癬","Psoriasis","IDI","定性","医師","皮膚科医","20","過去1ヶ月に中程度と重度の乾癬患者を合計で10人以上診療","","キャンドゥ","Holden","2025-06-25"
"眼科用顕微鏡","Ophthalmic surgical microscope","Webアンケート","定量","医師","白内障専門医","35","1ヶ月に白内障専門医は白内障／網膜硝子体／低侵襲緑内障／屈折矯正手術を20件以上、網膜専門医は白内障／網膜硝子体手術を12件以上行っていること","","日経BP","Holden","2025-06-26"
"眼科用顕微鏡","Ophthalmic surgical microscope","Webアンケート","定量","医師","網膜専門医","45","1ヶ月に白内障専門医は白内障／網膜硝子体／低侵襲緑内障／屈折矯正手術を20件以上、網膜専門医は白内障／網膜硝子体手術を12件以上行っていること","","日経BP","Holden","2025-06-27"
"全身性エリテマトーデス","SLE","IDI","定性","医師","リウマチ科","9","過去12ヶ月に全身性エリテマトーデス(SLE) 患者を20人以上診療、皮膚エリテマトーデス(CLE) を2人以上診療","","キャンドゥ","Holden","2025-06-28"
"慢性特発性蕁麻疹","CSU","IDI","定性","医師","皮膚科","6","1ヶ月に従来型(Traditional)の患者を1人以上、または革新型( Innovator)の患者を3人以上診療","","キャンドゥ","Holden","2025-06-29"
"慢性特発性蕁麻疹","CSU","IDI","定性","医師","内科","1","1ヶ月に従来型(Traditional)の患者を1人以上、または革新型( Innovator)の患者を3人以上診療","","キャンドゥ","Holden","2025-06-30"
"アルコール関連肝疾患","ALD/metALD","IDI","定性","医師","一般内科/総合診療科","6","直近3ヶ月に進行性肝疾患(MetALD / ALD)患者を5人以上、代謝異常関連脂肪性肝炎(MASH) 患者を5人以上診療","","キャンドゥ","Holden","2025-07-01"
"アルコール関連肝疾患","ALD/metALD","IDI","定性","医師","精神科","5","直近3ヶ月に進行性肝疾患(MetALD / ALD)患者を5人以上、代謝異常関連脂肪性肝炎(MASH) 患者を5人以上診療","","キャンドゥ","Holden","2025-07-02"
"アルコール関連肝疾患","ALD/metALD","IDI","定性","医師","肝臓専門医/肝胆膵専門医","8","直近3ヶ月に進行性肝疾患(MetALD / ALD)患者を5人以上、代謝異常関連脂肪性肝炎(MASH) 患者を5人以上診療","","キャンドゥ","Holden","2025-07-03"
"アルコール関連肝疾患","ALD/metALD","IDI","定性","医師","消化器専門医","4","直近3ヶ月に進行性肝疾患(MetALD / ALD)患者を5人以上、代謝異常関連脂肪性肝炎(MASH) 患者を5人以上診療","","キャンドゥ","Holden","2025-07-04"
"アルコール関連肝疾患","ALD/metALD","IDI","定性","医師","内分泌/代謝専門医","6","直近3ヶ月に進行性肝疾患(MetALD / ALD)患者を5人以上、代謝異常関連脂肪性肝炎(MASH) 患者を5人以上診療","","キャンドゥ","Holden","2025-07-05"
"IgA腎症治療薬の名称に関するアンケート調査","Survey on the Naming of Therapeutic Drugs for IgA Nephropathy","Webアンケート","定量","医師","腎臓内科","","過去3ヶ月にIgA腎症患者を3人以上診療","","不明","Holden","2025-07-06"
"IgA腎症治療薬の名称に関するアンケート調査","Survey on the Naming of Therapeutic Drugs for IgA Nephropathy","Webアンケート","定量","看護師","","","腎臓内科、もしくは透析室の看護師として勤務","","不明","Holden","2025-07-07"
"IgA腎症治療薬の名称に関するアンケート調査","Survey on the Naming of Therapeutic Drugs for IgA Nephropathy","Webアンケート","定量","薬剤師","","","病院での勤務を主としており、全体の勤務割合のうち病院薬剤師としての勤務割合が50％以上","","不明","Holden","2025-07-08"
"閉鎖式薬物移送システム","CSTD","会場調査","定性","看護師","","18","CSTDの使用経験があり、看護師・薬剤師として週24時間勤務","","キャンドゥ","Holden","2025-07-09"
"閉鎖式薬物移送システム","CSTD","会場調査","定性","薬剤師","","17","CSTDの使用経験があり、看護師・薬剤師として週24時間勤務","","キャンドゥ","Holden","2025-07-10"
"軟性尿管鏡検査処置","Flexible ureteroscopy procedure","Webアンケート","定量","医師","泌尿器科","20","1年間で軟性尿管鏡検査処置を20件以上実施しており、特定の軟性尿管鏡検査機器ブランドを使用している","","日経BP","Holden","2025-07-11"
"全身性エリテマトーデス","SLE","Webアンケート","定量","医師","腎臓内科（内科含む）","15","１ヶ月に50人以上の患者を診療","","日経BP","Holden","2025-07-12"
"全身性エリテマトーデス","SLE","Webアンケート","定量","医師","リウマチ・膠原病内科(内科含)","5","１ヶ月に50人以上の患者を診療","","日経BP","Holden","2025-07-13"
"多発性骨髄腫","MM","Webアンケート","定量","医師","血液内科/腫瘍内科/腫瘍外科","40","過去3か月間に薬物療法を開始した（導入療法、維持療法を問わず）2L以降のMM患者合計が①リスト内：3名以上②リスト外：5名以上","","日経BP","Holden","2025-07-14"
"HIV(ヒト免疫不全ウイルス)","HIV","IDI","定性","患者","不明","","18歳以上でHIVと診断されている","","","Holden","2025-07-15"
"好酸球性食道炎																																","EoE","IDI","定性","医師","消化器内科","7","過去12ヶ月に好酸球性食道炎患者を5人以上診療																								","","キャンドゥ","Holden","2025-07-16"
"非小細胞肺がん","Non-Small Cell Lung Cance, NSCLC","IDI","定性","医師","呼吸器外科","11","過去6ヶ月にIIA～IIIB期の非小細胞肺がん（NSCLC）患者を7人以上診療","","キャンドゥ","Holden","2025-07-17"
"デュシェンヌ型筋ジストロフィー","DMD","Webアンケート","定量","医師","脳神経内科/小児神経科","10","過去12か月に大学病院の場合は５名以上、一般病院は１名以上DMD患者を診療","","日経BP","Holden","2025-07-18"
"血友病B","Hemophilia B","Webアンケート","定量","医師","不明","","過去12ヶ月に血友病患者を1人以上診療？","","","Holden","2025-07-19"
"複数癌種","Multiple Cancer Types","不明","定量","医師","不明","20","不明","","","Holden","2025-07-20"
"アトピー性皮膚炎・結節性痒疹","Atopic dermatitis/Prurigo nodularis","Webアンケート","定量","医師","アレルギー科/皮膚科","","15歳以上の中等度～重度のアトピー性皮膚炎患者さんを月に5名以上、結節性痒疹患者さんは月に5名以上診療","","日経BP","Holden","2025-07-21"
"パーキンソン病","Parkinson's Disease","IDI","定性","患者","","","18～64歳のパーキンソン病と診断されホーン・ヤールの重症度分類が1～3度、治療にレポドパを使用している患者及び、患者の18歳以上の介護者","","アスマーク","Holden","2025-07-22"
"パーキンソン病","Parkinson's Disease","IDI","定性","介護者","","","18～64歳のパーキンソン病と診断されホーン・ヤールの重症度分類が1～3度、治療にレポドパを使用している患者及び、患者の18歳以上の介護者","","アスマーク","Holden","2025-07-23"
"パーキンソン病","Parkinson's Disease","IDI","定性","患者","","","18～64歳のパーキンソン病と診断されホーン・ヤールの重症度分類が1～3度、治療にレポドパを使用している患者及び、患者の18歳以上の介護者","","3Hメディソリューションズ","Holden","2025-07-24"
"パーキンソン病","Parkinson's Disease","IDI","定性","介護者","","","18～64歳のパーキンソン病と診断されホーン・ヤールの重症度分類が1～3度、治療にレポドパを使用している患者及び、患者の18歳以上の介護者","","3Hメディソリューションズ","Holden","2025-07-25"
"統合失調症","Schizophrenia","Webアンケート","定量","医師","精神科","40","1ヶ月に統合失調症の成人患者を40名以上診療","","日経BP","Holden","2025-07-26"
"小児グリオーマ","Pediatric Glioma","IDI","定性","医師","小児科","3","過去2年間に神経線維腫症1型患者を1人以上診療","","キャンドゥ","Holden","2025-07-27"
"小児グリオーマ","Pediatric Glioma","IDI","定性","医師","脳神経外科","4","過去2年間に神経線維腫症1型患者を1人以上診療","","キャンドゥ","Holden","2025-07-28"
"経皮的僧帽弁接合不全修復術","経皮的僧帽弁接合不全修復術（Transcatheter Edge-to-Edge Repair, TEER","Webアンケート","定量","医師","循環器科","20","経皮的僧帽弁接合不全修復システム術認定施設で経皮的僧帽弁接合不全修復術（TEER）の手技を行っている。","","日経BP","Holden","2025-07-29"
"頭頸部扁平上皮癌","HNSCC","IDI","定性","医師","耳鼻咽喉科／頭頸部外科 ","8","頭頸部がんを専門とする耳鼻咽喉科医または口腔顎顔面外科医 。インターベンショナル・ラジオロジスト、インターベンショナル・ニューロラジオロジスト、頭頸部癌の経験を有する頭頸部診断放射線科医。頭頸部がんの経験を持つ放射線腫瘍科医。頭頸部がんの経験を持つ腫瘍内科医。","","キャンドゥ","Holden","2025-07-30"
"頭頸部扁平上皮癌","HNSCC","IDI","定性","医師","腫瘍内科","1","頭頸部がんを専門とする耳鼻咽喉科医または口腔顎顔面外科医 。インターベンショナル・ラジオロジスト、インターベンショナル・ニューロラジオロジスト、頭頸部癌の経験を有する頭頸部診断放射線科医。頭頸部がんの経験を持つ放射線腫瘍科医。頭頸部がんの経験を持つ腫瘍内科医。","","キャンドゥ","Holden","2025-07-31"
"外科手術用製品のパッケージングに係る調査","Packaging for surgical-use products","IDI","定性","医師","外科","2","病院訪問、外科手術用製品のパッケージングに係る調査","","","Holden","2025-08-01"
"外科手術用製品のパッケージングに係る調査","Packaging for surgical-use products","IDI","定性","看護師","","7","病院訪問、外科手術用製品のパッケージングに係る調査","","","Holden","2025-08-02"
"外科手術用製品のパッケージングに係る調査","Packaging for surgical-use products","IDI","定性","その他(S＆Rアソシエイト)","","2","病院訪問、外科手術用製品のパッケージングに係る調査","","","Holden","2025-08-03"
"外科手術用製品のパッケージングに係る調査","Packaging for surgical-use products","IDI","定性","その他(マテリアルマネジャー)","","2","病院訪問、外科手術用製品のパッケージングに係る調査","","","Holden","2025-08-04"
"外科手術用製品のパッケージングに係る調査","Packaging for surgical-use products","IDI","定性","その他(サプライルームマネジャー)","","1","病院訪問、外科手術用製品のパッケージングに係る調査","","","Holden","2025-08-05"
"自閉スペクトラム症 ","ASD","Webアンケート","定量","医師","消化器内科、一般内科、腫瘍内科、消化器外科、一般外科","30","過去3ヵ月に0~17歳自閉スペクトラム症 (ASD)患者を20人以上診療","","日経BP","Holden","2025-08-06"
"転移性大腸がん","mCRC","Webアンケート","定量","医師","腫瘍内科、血液腫瘍内科","5","転移性大腸がん患者を6人以上診療","","日経BP","Holden","2025-08-07"
"転移性大腸がん","mCRC","Webアンケート","定量","医師","消化器内科","60","転移性大腸がん患者を6人以上診療","","日経BP","Holden","2025-08-08"
"前立腺がん","Prostate cancer","Webアンケート","定量","医師","泌尿器科、泌尿器腫瘍科、放射線科、核医学科","","過去3ヶ月で前立腺がん患者を15人以上。転移性去勢抵抗性前立腺がん患者を3人以上診療","","日経BP","Holden","2025-08-09"
"多発性骨髄腫","Multiple Myeloma","会場調査","定量","医師","腫瘍内科、血液内科、血液腫瘍内科","22","多発性骨髄腫（症候性多発性骨髄腫）患者を10人以上診療。","","日経BP","Holden","2025-08-10"
"2型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","患者","","12","25～60歳、6ヶ月以上15年以内に2型糖尿病と診断され、医師からHbA1cをコントロールできていないと言われ、内服薬、インスリン以外の注射、または基礎インスリンを使用している","GLP-1","アスマーク","The Link Group","2025-08-11"
"2型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","患者","","12","過去6ヶ月から15年以内に2型糖尿病と診断され、A1cが7以上で、主治医からA1cをコントロールできていないと言われている患者","GLP-1","アスマーク","The Link Group","2025-08-12"
"2型糖尿病","Type 2 Diabetes Mellitus, T2DM","IDI","定性","患者","","10","過去6ヶ月から15年以内に2型糖尿病と診断され、直近のA1c値が7以上ある、現在経口薬、インスリン以外の注射、または基礎インスリンで治療中、今後注射薬を使用する可能性がある","GLP-1","アスマーク","The Link Group","2025-08-13"
"2型糖尿病","T2D","IDI","定性","患者","","10","年齢25～70歳で6ヶ月より前に2型糖尿病と診断された","","アスマーク","Escalent","2025-08-14"
"2型糖尿病","T2D","IDI","定性","患者","","10","25～70歳で6ヶ月より前に2型糖尿病と診断され現在注射薬を使用しておらず基礎インスリンまたは食事前に投与するインスリンを使用したことがない 患者","","アスマーク","Escalent","2025-08-15"
"IgA腎症","IgA nephropathy, IgAN","IDI","定性","患者","","3","IgA腎症の診断確定に腎生検を受けた、腎臓内科／腎臓専門医を受診している","シベプレンリマブ","アスマーク","The Link Group","2025-08-16"
"IgA腎症","IgA nephropathy, IgAN","IDI","定性","患者","","1","IgA腎症の診断確定に腎生検を受けた、腎臓内科／腎臓専門医を受診している","シベプレンリマブ","3H","The Link Group","2025-08-17"
"アルコール・タバコ使用障害","Alcohol and Tobacco Use Disorders","会場調査・IDI","定性","患者","","8","週に1～2回以上アルコールを飲む","チルゼパチド,マンジャロ","アスマーク","The Link Group","2025-08-18"
"アルコール・タバコ使用障害","Alcohol and Tobacco Use Disorders","会場調査・IDI","定性","患者","","8","1日に何度も紙巻タバコを吸う","チルゼパチド,マンジャロ","アスマーク","The Link Group","2025-08-19"
"アルツハイマー型認知症","Alzheimer's Disease, AD","IDI","定性","介護者","","3","軽度認知障害または軽度アルツハイマー型認知症と診断された患者の家族であること。","レカネマブ,レケンビ","3H","Blue Matter Consulting","2025-08-20"
"アルツハイマー型認知症","Alzheimer's Disease, AD","IDI","定性","介護者","","1","軽度認知障害または軽度アルツハイマー型認知症と診断された患者の家族であること。","レカネマブ,レケンビ","アスマーク","Blue Matter Consulting","2025-08-21"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","患者","","6","記憶力や思考力が以前とは違うと感じADと診断されている場合は、早期、軽度まで","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-08-22"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Group","定性","患者","","16","記憶力や思考力が以前とは違うと感じADと診断されている場合は、早期、軽度まで","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-08-23"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","患者","","4","記憶力や思考力が以前とは違うと感じADと診断されている場合は、早期、軽度まで","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-08-24"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","患者","","10","記憶力や思考力が以前とは違うと感じADと診断されている場合は、早期、軽度まで","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-08-25"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","患者","","6","記憶力や思考力が以前とは違うと感じADと診断されている場合は、早期、軽度まで","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-08-26"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","患者","","8","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度まで","TAUVID","アスマーク","The Link Group","2025-08-27"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","患者","","6","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度まで","TAUVID","アスマーク","The Link Group","2025-08-28"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","患者","","8","記憶力や思考力が以前とは違うと感じ、アルツハイマーと診断されている場合は、早期、軽度まで","TAUVID","アスマーク","The Link Group","2025-08-29"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","IDI","定性","患者","","8","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度まで","TAUVID","アスマーク","The Link Group","2025-08-30"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/MCI","IDI","定性","患者","","4","60~75歳で記憶力と思考力のための薬物療法に少なくとも「ある程度」前向きである MCIまたは軽度ADと診断されている過去2年間に医師を受診した患者","","アスマーク","Escalent","2025-08-31"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/MCI","IDI","定性","患者","","3","55~80歳でアルツハイマー型認知症または軽度認知障害と診断されている","","アスマーク","Escalent","2025-09-01"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","介護者","","4","記憶力や思考力が以前とは違うと感じADと診断されている場合は、軽度までの患者さんご家族","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-09-02"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","介護者","","6","記憶力や思考力が以前とは違うと感じADと診断されている場合は、軽度までの患者さんご家族","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-09-03"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","介護者","","6","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度まで","TAUVID","アスマーク","The Link Group","2025-09-04"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","患者","","4","記憶力や思考力が以前とは違うと感じADと診断されている場合は、早期、軽度まで","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-09-05"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","Dyad","定性","患者","","6","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度までの患者さんとご家族","TAUVID","アスマーク","The Link Group","2025-09-06"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","Dyad","定性","患者","","6","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度までの患者さんとご家族","TAUVID","アスマーク","The Link Group","2025-09-07"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","会場調査・Dyad","定性","介護者","","4","記憶力や思考力が以前とは違うと感じADと診断されている場合は、軽度までの患者さんご家族","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-09-08"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","Dyad","定性","介護者","","6","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度までの患者さんとご家族","TAUVID","アスマーク","The Link Group","2025-09-09"
"アルツハイマー型認知症／軽度認知障害","Alzheimer's Disease, AD/Mild Cognitive Impairment, MCI","Dyad","定性","介護者","","6","記憶力や思考力が以前とは違うと感じ、ADと診断されている場合は、早期、軽度までの患者さんとご家族","TAUVID","アスマーク","The Link Group","2025-09-10"
"アルツハイマー病","Alzheimer's Disease, AD","IDI","定性","介護者","","4","アルツハイマー以外の神経疾患のご家族をサポートしている","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-09-11"
"クローン病","Crohn's disease, CD","IDI","定性","患者","","7","中等度から重度のクローン病で3～25年前に診断され、治療薬を現在服用／使用している、または過去に服用／使用していた																																														","ミリキズマブ,オンボー","アスマーク","The Link Group","2025-09-12"
"クローン病","Crohn's disease, CD","IDI","定性","患者","","1","中等度から重度のクローン病で3～25年前に診断され、治療薬を現在服用／使用している、または過去に服用／使用していた																																														","ミリキズマブ,オンボー","3H","The Link Group","2025-09-13"
"ナルコレプシー","Narcolepsy","IDI","定性","患者","","5","18歳以上のナルコレプシーと診断された患者","","3Hメディソリューションズ","Fieldcats","2025-09-14"
"パーキンソン病","Parkinson's Disease","IDI","定性","患者","","","18～64歳のパーキンソン病と診断されホーン・ヤールの重症度分類が1～3度、治療にレポドパを使用している患者及び、患者の18歳以上の介護者","","アスマーク","Holden","2025-09-15"
"パーキンソン病","Parkinson's Disease","IDI","定性","患者","","","18～64歳のパーキンソン病と診断されホーン・ヤールの重症度分類が1～3度、治療にレポドパを使用している患者及び、患者の18歳以上の介護者","","3Hメディソリューションズ","Holden","2025-09-16"
"パーキンソン病","Parkinson's Disease","IDI","定性","介護者","","","18～64歳のパーキンソン病と診断されホーン・ヤールの重症度分類が1～3度、治療にレポドパを使用している患者及び、患者の18歳以上の介護者","","アスマーク","Holden","2025-09-17"
"パーキンソン病","Parkinson's Disease","IDI","定性","介護者","","","18～64歳のパーキンソン病と診断されホーン・ヤールの重症度分類が1～3度、治療にレポドパを使用している患者及び、患者の18歳以上の介護者","","3Hメディソリューションズ","Holden","2025-09-18"
"腹膜透析","Peritoneal Dialysis, PD","IDI","定性","患者","","3","腹膜透析を6ヵ月以上実施している患者","","SNS","The Link Group","2025-09-19"
"プレクリニカルアルツハイマー病","Preclinical Alzheimer's Disease, PCAD","IDI","定性","患者","","16","55~79歳のアルツハイマー病及び、認知症（血管性、レビー小体型、ピック型、前頭側頭型を含む） と診断されたことのないプレクリニカル患者及びMCI患者 ","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-09-20"
"プレクリニカルアルツハイマー病","Preclinical Alzheimer's Disease, PCAD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","患者","","10","脳神経系の疾患の診断を受けておらず、薬や自分の将来について積極的であること","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-09-21"
"プレクリニカルアルツハイマー病","Preclinical Alzheimer's Disease, PCAD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","患者","","12","脳神経系の疾患の診断を受けておらず脳の健康状態に前向きであり、過去一年で目立った記憶力の低下がない","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-09-22"
"プレクリニカルアルツハイマー病","Preclinical Alzheimer’s Disease","IDI","定性","患者","","11","55～80歳の前臨床と分類され認知機能低下の徴候や症状がなく記憶力／思考力の健康に関する検査や薬物療法に前向きでアルツハイマーの家族歴がある ","","アスマーク","Escalent","2025-09-23"
"プレクリニカルアルツハイマー病","Preclinical Alzheimer's Disease, PCAD/Mild Cognitive Impairment, MCI","会場調査・IDI","定性","介護者","","3","脳神経系の疾患の診断を受けておらず、薬や自分の将来について積極的な患者さんを介護しているご家族","ドナネマブ,ケサンラ","アスマーク","The Link Group","2025-09-24"
"局所進行結腸がん ","Locally advanced colon cancer","IDI","定性","患者","","6","18～75歳の結腸がんと診断された抗がん剤治療と手術を受けた患者","","3Hメディソリューションズ","Holden","2025-09-25"
"局所進行結腸がん ","Locally advanced colon cancer","IDI","定性","介護者","","1","18～75歳の結腸がんと診断された抗がん剤治療と手術を受けた患者の介護者","","3Hメディソリューションズ","Holden","2025-09-26"
"局所進行性切除不能膵がん																																				","Locally advanced unresectable pancreatic cancer","IDI","定性","患者","","4","18～75歳で局所進行、切除不能、転移なし の膵臓がんと診断された患者またはその介護者","","3Hメディソリューションズ/キャンドゥ","Fieldcats","2025-09-27"
"潰瘍性大腸炎","Ulcerative Colitis","IDI","定性","患者","","","18歳以上で過去10年以内に潰瘍性大腸炎と診断された患者","","3Hメディソリューションズ","Fieldcats","2025-09-28"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","患者","","5","転移性ホルモン感受性前立腺がんと診断され、現在治療を受けている、または過去に治療を受けていた","アベマシクリブ,ベージニオ","アスマーク","The Link Group","2025-09-29"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","患者","","3","転移性去勢抵抗性前立腺がんと診断され、現在治療を受けている、または過去に治療を受けていた","アベマシクリブ,ベージニオ","アスマーク","The Link Group","2025-09-30"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","患者","","1","転移性去勢抵抗性前立腺がんと診断され、現在治療を受けている、または過去に治療を受けていた","アベマシクリブ,ベージニオ","3Hメディソリューションズ","The Link Group","2025-10-01"
"転移性前立腺がん","Metastatic Prostate Cancer","IDI","定性","患者","","12","40～75歳で転移性前立腺がんと診断されている","","アスマーク/3Hメディソリューション","Escalent","2025-10-02"
"統合失調症","Schizophrenia","IDI","定性","患者","","4","１年以上前に診断を受け、1年以内に医師の診察を受けている18～64歳の統合失調症患者","ウロタロント","アスマーク","The Link Group","2025-10-03"
"統合失調症","Schizophrenia","IDI","定性","介護者","","4","１年以上前に診断を受け、1年以内に医師の診察を受けている18～64歳の統合失調症患者さんをサポートしているご家族","ウロタロント","アスマーク","The Link Group","2025-10-04"
"動脈硬化性心疾患","Atherosclerotic Cardiovascular Disease, ASCVD","IDI","定性","患者","","5","1次予防患者：動脈硬化性脳血管障害、冠動脈疾患、末梢動脈疾患、2型糖尿病のいずれかと診断されている、心血管の健康管理のために薬剤を服用している、または服用していた","Lp(a)阻害剤","アスマーク","The Link Group","2025-10-05"
"動脈硬化性心疾患","Atherosclerotic Cardiovascular Disease, ASCVD","IDI","定性","患者","","4","2次予防患者：CVイベントの既往歴あり、心血管の健康管理のために薬剤を服用している、または服用していた","Lp(a)阻害剤","アスマーク","The Link Group","2025-10-06"
"肥満症","Obesity","IDI","定性","患者","","10","BMIが27以上、過去に減量経験がある、体重と将来の健康を心配している、体重減少をもたらす処方箋の減量薬服用を検討する","GLP-1","アスマーク","The Link Group","2025-10-07"
"肥満症","Obesity","IDI","定性","患者","","12","18~79歳で自分の体重が将来の健康に影響を与える可能性を多少～非常に心配しているBMI 27-39.9、かつ肥満症関連疾患(ORC)がある人","","アスマーク","Escalent","2025-10-08"
"肥満症","Obesity","IDI","定性","患者","","15","20~66歳でBMI24以上","","アスマーク","Escalent","2025-10-09"
"肥満症","Obesity","IDI","定性","患者","","10","18歳以上の高度肥満症または肥満症を有する成人","","アスマーク","Fieldcats","2025-10-10"
"非閉塞性肥大型心筋症																																						","nHCM","IDI","定性","患者","","1","18歳以上で肥大型心筋症(HCM)／家族性肥大型心筋症 と診断されている","","3Hメディソリューションズ/キャンドゥ/アスマーク","Fieldcats","2025-10-11"
"鼻茸を伴う慢性副鼻腔炎","Chronic Rhinosinusitis with Nasal Polyps, CRSwNP","IDI","定性","患者","","3","鼻茸を伴う慢性副鼻腔炎と診断され、生物学的製剤などの薬剤を使用したことがある","レブリキズマブ,イブグリース","アスマーク","The Link Group","2025-10-12"
"鼻茸を伴う慢性副鼻腔炎","Chronic Rhinosinusitis with Nasal Polyps, CRSwNP","IDI","定性","患者","","3","鼻茸を伴う慢性副鼻腔炎と診断され、現在、アレルギー科、耳鼻咽喉科、アレルギー呼吸科のいずれかで診療を受けている。","レブリキズマブ,イブグリース","アスマーク","The Link Group","2025-10-13"
"慢性炎症性脱髄性多発根神経炎																																							","CIDP","IDI","定性","患者","","6","18～75歳 でCIDPと診断されてから1年以上経過しており診断にあたり神経電動検査を受けている。過去６ヶ月以上に専門医を受診し、現在、CIDP治療に処方薬を服用／使用中。CIDPにより、日常生活に影響がある(多少～著しい影響）患者																	","","3Hメディソリューションズ/キャンドゥ","Fieldcats","2025-10-14"
"慢性閉塞性肺疾患","COPD","IDI","定性","患者","","11","40～85歳で慢性閉塞性肺疾患(COPD)、慢性気管支炎、肺気腫と診断され、現在治療薬を使用/服用している患者	または、患者を介護している18歳以上の介護者																	","","3Hメディソリューションズ","Fieldcats","2025-10-15"
"慢性閉塞性肺疾患","COPD","IDI","定性","介護者","","3","40～85歳で慢性閉塞性肺疾患(COPD)、慢性気管支炎、肺気腫と診断され、現在治療薬を使用/服用している患者	または、患者を介護している18歳以上の介護者																	","","3Hメディソリューションズ","Fieldcats","2025-10-16"
"TEST","","TEST","TEST","医師","","1","","","","","2025-10-17"
"ATTRアミロイドーシス","ATTR, ATTR-CM","IDI","定性","医師","神経内科","7","過去12ヵ月で3人以上のATTR-CMまたはhATTR-PN の患者を診ていること","","キャンドゥ","MarketVision","2025-10-18"
"ATTR-CM アミロイドーシス","ATTR, ATTR-CM","IDI","定性","医師","循環器科","7","過去12ヵ月で3人以上のATTR-CMまたはhATTR-PNの患者を診ていること","","キャンドゥ","MarketVision","2025-10-19"
"ASCVD","ASCVD","IDI","定性","医師","神経内科","6","直近3か月のASCVD患者＞30名、除外条件＝ 直近3か月の主要イベント既往ASCVD患者＞20名","","キャンドゥ","Holden","2025-10-21"
"ASCVD","ASCVD","IDI","定性","医師","神経内科","8","TEST","","キャンドゥ","Holden","2025-10-21"
"テスト疾患（デプロイ確認）","TEST","IDI","定性","医師","内科","5","Worker デプロイテスト用データ","テスト薬剤","テスト会社","Test Client","2025-10-22"
